AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Gr. Sarantis S.A.

Interim / Quarterly Report Sep 15, 2021

2712_ir_2021-09-15_93e49a00-b29b-4fe1-8a4a-306efeb8c0d5.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

1. STATEMENTS BY MEMBERS OF THE BOARD OF DIRECTORS 4
2. SEMI-ANNUAL BOARD OF DIRECTORS' MANAGEMENT REPORT 6
2.1 INTRODUCTION 6
2.2 PERFORMANCE AND FINANCIAL POSITION 6
2.3 SIGNIFICANT EVENTS DURING THE 1ST HALF OF 2021 8
2.4 MAJOR RISKS AND UNCERTAINTIES FOR THE 2nd HALF OF 2021 11
2.5 FUTURE OUTLOOK AND PROSPECTS 13
2.6 RELATED PARTY TRANSACTIONS 14
2.7 Information concerning the acquired Treasury Shares according to article 50, paragraph 2, Law 4548/2018. 17
2.8 SUBSEQUENT EVENTS 17
2.9 ALTERNATIVE PERFORMANCE MEASURES ("APMs") 17
3. REPORT ON REVIEW OF THE INTERIM FINANCIAL INFORMATION20
4. INTERIM CONDENSED FINANCIAL STATEMENTS 22
4.1 STATEMENT OF FINANCIAL POSITION 23
4.2 INTERIM CONDENSED ITEMS OF THE STATEMENT OF INCOME 24
4.3 INTERIM CONDENSED STATEMENT OF CHANGES IN GROUP'S EQUITY FOR THE PERIOD 25
4.4 INTERIM CONDENSED STATEMENT OF CHANGES IN COMPANY'S EQUITY FOR THE PERIOD 26
4.5 INTERIM CONDENSED STATEMENT OF CASH FLOWS 27
4.6 NOTES ON THE INTERIM CONDENSED FINANCIAL STATEMENTS 28
4.6.1 The Company 28
4.6.2 Group Structure 28
4.7 BASIS FOR THE PREPARATION OF THE FINANCIAL STATEMENTS 29
4.7.1 Compliance with IFRS 29
4.7.2 Basis for the preparation of the financial statements29
4.7.3 Approval of financial statements 29
4.7.4 Covered Period29
4.7.5 Presentation of the financial statements29
4.7.6 Significant judgments and estimations by Management29
4.7.7 Significant Accounting Policies31
4.8 FINANCIAL RISK MANAGEMENT 32
4.8.1 Capital Management32
4.8.2 Financial Instruments33
4.8.3 Definition of fair values33
4.9 EXPLANATORY NOTES ON THE FINANCIAL STATEMENTS 34
4.9.1 Segment Reporting34
4.9.2 Investments in associate companies36
4.9.3 Goodwill 36
4.9.4 Inventories 36
4.9.5 Trade and other receivables37
4.9.6 Cash & cash equivalents39
4.9.7 Financial Assets at Fair Value through Results39
4.9.8 Trade and other liabilities 39
4.9.9 Provisions and other long-term liabilities 40
4.9.10 Loans 41
4.9.11 Income tax41
4.9.12 Financial Income / Expenses 41
4.9.13 Share Capital 42
4.9.14 Earnings per Share 42
4.9.15 Dividends42
4.9.16 Treasury Shares42
4.9.17 Table of changes in fixed assets43
4.9.18 Number of Employees49
4.9.19 Litigation Cases49
4.9.20 Contingent Liabilities49
4.9.21 Contractual Obligations49
4.9.22 Events after the Balance Sheet Date49
4.9.23 Related party transactions50
4.9.24 Business Units and Geographical Analysis Tables53

1. STATEMENTS BY MEMBERS OF THE BOARD OF DIRECTORS

Statements by Members of the Board of Directors (according to article 5 of Law 3556/2007)

It is hereby declared that to our knowledge:

a) The Semi-Annual Condensed Financial Statements (Parent and Consolidated) of the company "GR. SARANTIS S.A." for the period from 1 January 2021 to 30 June 2021, which were prepared according to the International Financial Reporting Standards (IFRS) that were adopted by the European Union and specifically based on the International Accounting Standard (IAS) 34 "Interim Financial Reporting", accurately present the assets and liabilities, equity and results for the aforementioned period of the Company as well as those of the companies included in the consolidation, considered as a whole, according to the provisions of paragraphs 3 to 5 of article 5, Law 3556/2007.

b) The Semi-Annual Report of the Board of Directors reflects in a true manner the information required according to the paragraph 6 of article 5 of Law 3556/2007, namely the significant events that took place during the first half of the fiscal year and their effect on the semi-annual financial statements, the development, performance and financial position of the Company as well as of the businesses included in the Group consolidation, considered as a whole, including the description of the principal risks and uncertainties for the second half of the fiscal year, and also the significant transactions that concerned the Company and the businesses included in the consolidation, and furthermore the transactions with the related parties.

Marousi, September 8 th 2021 The Members of the Board

THE CHAIRMAN OF THE BOARD MANAGING DIRECTOR THE GROUP'S CHIEF FINANCIAL
OFFICER & BOARD MEMBER
GRIGORIS SARANTIS KYRIAKOS SARANTIS KONSTANTINOS ROZAKEAS
ID NO. Χ 080619/03 ID NO. ΑΙ 597050/2010 ID NO. ΑΚ 783631/13

SEMI-ANNUAL REPORT OF THE BOARD OF DIRECTORS FOR THE PERIOD 01.01.2021 – 30.06.2021

2. SEMI-ANNUAL BOARD OF DIRECTORS' MANAGEMENT REPORT

SEMI-ANNUAL BOARD OF DIRECTORS' MANAGEMENT REPORT OF THE COMPANY GR. SARANTIS S.A.

on the Financial Statements for the period from 1 January to 30 June 2021

2.1 INTRODUCTION

The present report of the Board of Directors of "GR. SARANTIS S.A." (henceforth the "Company") has been compiled according to the provisions of article 5 of Law 3556/2007 as well as to the relevant decisions of the Board of Directors of the Hellenic Capital Market Commission and refers to the Interim Condensed financial statements (Consolidated and Separate) of 30th June 2021 and of the semi-annual period that ended on the above date.

The Report is included in the semi-annual financial report of the period 1.1.2021 - 30.06.2021, together with the Company's financial statements and other information and statements required by law.

The present report briefly presents the Company's financial information for the first half of the year 2019, significant events that occurred during the above mentioned period and their effects on the semi-annual financial statements. The report also includes a description of the basic risks and uncertainties the Group's companies may face during the second half of the current year. Finally, significant transactions between the issuer and its related parties are also presented.

The semi-annual separate and consolidated financial statements have been compiled according to the International Financial Reporting Standards (IFRS) which were adopted by the European Union and specifically based on the International Accounting Standard (IAS) 34 "Interim Financial Reporting".

The current Report also presents the Alternative Performance Measures in paragraph 2.9.

2.2 PERFORMANCE AND FINANCIAL POSITION

The Group's total turnover during H1 2021 reached €195.24 million from € 183.69 million in H1 2020, up by 6.29%, underpinned by the Group's ability to address different consumption patterns and channel dynamics in each country. Throughout the first half of 2021 sales were driven by all product categories related to home care and personal care, while the gradual reopening of the market in combination with higher consumer traffic, benefited the categories of fragrances, deodorants and suncare.

• Greece, presented sales of €69.25 million in H1 2021 compared to €67.64 mil. in H1 2020, up by 2.38%, with the mass market channel driving the growth and the Luxury Cosmetics gaining momentum following the reopening of the market and the increased consumption in the respective channel.

• The foreign countries, exhibited growth of 8.56% reaching €125.99 million in H1 2021 from €116.05 million in H1 2020.

The Group's profitability in H1 2021 benefited by tight control of gross profit and balanced operating expenses, while controlled advertising and promotion expenses were reactivated and allocated behind strategic initiatives.

Specifically:

  • EBITDA* was up by 10.13% to € 31.32 mil. in H1 2021 from €28.44 mil. in H1 2020, with an EBITDA margin of 16.04% from 15.48% in H1 2020.
  • EBIT reached € 24.90 mil. during H1 2021 versus € 22.26 mil. in last year's first half, increased by 11.88%, and EBIT margin stood at 12.75% from 12.12% in H1 2020.

• EBT settled at €24.71 mil. in H1 2021 from €19.63 mil. in H1 2020, increased by 25.89%, with the EBT margin reaching 12.66% from 10.69% in the previous year's first half.

• Net Profit reached €19.51 mil. in H1 2021 from €15.62 mil. in the previous year's first half, up by 24.90%, while Net Profit margin settled at 9.99% from 8.50% in H1 2020.

*Alternative Performance Measures, as defined within paragraph 2.9.

The Group exhibits a healthy financial position supported by the improving profitability of the business, and balanced capital expenditure.

Despite the challenges posed by the COVID-19 pandemic, the Group, committed to its strategy, invests the cash generated by the business behind initiatives to accelerate growth, either organically or through acquisitions, and to return value to its shareholders.

Within 2021, the Group paid a dividend for FY 2020 of approximately €15 mil. (0.22393 euros per share), increased by 34% compared to last year's dividend payment.

As of the first half of 2021 the Group's net debt over EBITDA ratio stood at 0.54x, with a net debt position reaching €35.38 mil., from € 10.91 mil as of the end of 2020, as a result of the dividend payment and investments that are largely related to the construction of Polipak's new production facility as well as machinery equipment at Oinofyta's production plant.

Polipak's new garbage bags production plant will lead to a more automated production process, which, combined with a new R&D and new equipment, will result in higher production capacity, increased efficiency and products improved in terms of ecological profile, durability and functionality.

As part of its strategy to further grow sales and profits organically, emphasis is given in optimizing the Group's product portfolio, leveraging the strong brand equity within its strategic product categories. Targeted investments and innovation plans will be allocated behind strategic product development initiatives in order to drive further growth across our territory.

Moreover, investments relating to infrastructure, systems, processes, and models have been enabled in order to increase further the Group's efficiency and effectiveness.

Regarding sales breakdown per business unit, Personal Care products sales were up by 8.02% yoy to €85.09 mil. in H1 2021 from €78.11 mil. in H1 2020, supported by growth in the own brands portfolio, that increased by 12.22%. This performance reflects the continued strong demand in categories related to personal hygiene, such as face care, body care, body wash and wand wash, while the gradual reopening of the market benefited categories such as fragrances, deodorants and suncare. The category's participation to total Group turnover amounted to 43.58%.

Sales of Home Care increased by 6.22% amounting to €76.13 million from €71.67 million in the previous year's first half, supported by the own brands subcategory, and in particular driven by all product categories related to home care. The category's participation to total Group turnover amounted to 38.99%.

The category "Private Label" represents sales of Polipak, the Polish packaging products company, which specializes on the production of private label garbage bags. Sales of this category exhibited a 5.33% increase in H1 2021 amounting to €11.45 mil. from €10.87 mil. in H1 2020.

The category of Other Sales was up in sales by 0.84%, driven by the Luxury Cosmetics category that presented a 3.28% sales growth as a result of the reopening of the market and increased consumption within this channel.

Regarding operating profits per business unit, Personal Care products EBIT settled at €5.85 million from €5.05 million in the first half of the previous year, up by 15.92%, driven by the own Personal Care products subcategory that presented an EBIT growth of 22.84%. The margin of Personal Care products stood at 6.88% in H1 2021.

The EBIT of Home Care products posted an increase of 12.20% during H1 2021 to €9.56 million from €8.52 million in H1 2020, driven by the own brands subcategory that was up by 11.50%. The EBIT margin of the Home Care products stood at 12.56% during H1 2021 from 11.89% in H1 2020 and their participation to total Group EBIT settled at 38.41% in H1 2021.

The EBIT of the Other Sales category was up by 2.03% to € 2.04 mil. from € 2.00 mil., driven by the Luxury Cosmetics subcategory.

The income from Associated Companies represents the income from the Estee Lauder JV that stood at €6.35 mil. up by 23.25% vs last year's first half, as a result of the re-opening of the market and increased consumption within this channel.

Regarding turnover breakdown by geographical region, Greece, presented sales of €69.25 million in H1 2021 compared to €67.64 mil. in H1 2020, up by 2.38%, with the mass market channel driving the growth and the Luxury

Cosmetics gaining momentum following the reopening of the market and the increased consumption in the respective channel.

The foreign countries, representing 64.53% of the Group's total sales, exhibited growth of 8.56% reaching €125.99 million in H1 2021 from €116.05 million in H1 2020.

Throughout the first half of 2021 and across the Group's region sales were driven by all product categories related to home care and personal care, while the gradual reopening of the market in combination with higher consumer traffic, benefited the categories of fragrances, deodorants and suncare.

Regarding operating profits per geographical region, the Greek EBIT during H1 2021 increased by 19.27% to €15.49 mil., from €12.99 mil. in H1 2020.

Excluding the income from Associated companies, Greek EBIT during H1 2021 amounted to €9.14 mil. up by 16.66% compared to €7.83 mil. last year's first half. Greek EBIT margin, excluding income from Associated Companies, stood at 13.20% during FY 2020 from 11.58% in H1 2020.

The foreign countries EBIT was up by 1.52% during H1 2021, amounting to €9.41 mil. from 9.27 mil. In the first half of last year. The foreign countries EBIT margin settled at 7.47% from 7.99% in H1 2020.

It is noted that:

  • ❖ The breakdown by product category and by geographical region is presented in detail in section 4.9.24 "Business Units and Geographical Analysis Tables".
  • ❖ References to sales in Greece are made at Group level, that is, having eliminated intra-group transactions.
  • ❖ References to the EBIT of Greece, as well as to the EBIT of the other countries, relate to the operating profitability as monitored by the management in order to serve the evaluation of the performance and to make a more efficient decision-making.

2.3 SIGNIFICANT EVENTS DURING THE 1ST HALF OF 2021

  • ❖ During February 24th 2021, the Extraordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the following items on the agenda:
  • Amendment of article 21 of the Company's articles of association.
  • Amendment of article 25 of the Company's articles of association.
  • Amendment of the Company's Remuneration Policy.
  • Free offer of shares to the Company's personnel in accordance with the provisions of article 114 of law 4548/2018; granting of authorization to the Board of Directors.
  • Amendment of the stock option plan.

Read the resolutions of the Extraordinary General Shareholders Meeting of February 24th 2021.

  • ❖ During May 20th 2021, the Ordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the following items on the agenda:
  • Submission and approval of the Annual Financial Statements along with the Management's and Statutory Auditor's Report, for the financial year 1.1.2020 - 31.12.2020.
  • Submission of the Annual Audit Committee report.
  • Approval of the overall management for the financial year 01.01.2020 31.12.2020.
  • Discharge of the Certified Auditors for the audit of the financial year 01.01.2020 31.12.2020.
  • Election of a regular and an alternate certified auditor for the ordinary and tax audit of the financial year 1.1.2021 - 31.12.2021, and approval of their fees.
  • Submission for discussion and voting of the Remuneration Report for the financial year 01.01.2020- 31.12.2020.
  • Amendment of the Company's Remuneration Policy.
  • Increase of the maximum number of the Board of Directors members from 11 to 15 and relevant amendment of article 8 of the Company's Articles of Association.
  • Election of a new Board of Directors and appointment of the independent & non-executive members of the Board of Directors.
  • Appointment of the Audit Committee members according to a.44 of L. 4449/2017.

Read the resolutions of the Ordinary General Shareholders Meeting of May 20th 2021.

  • ❖ Following the Annual General Meeting of the Company's Shareholders, which was held on May 20th, 2021, the Company's Board of Directors was formed into body on May 20th 2021, as follows:
    1. Grigoris P. Sarantis, Chairman-Executive member
    1. Dimitrios P. Reppas, Vice Chairman Independent non-executive member,
    1. Kyriakos P. Sarantis, Chief Executive Officer Executive member,
    1. Aikaterini P. Saranti, Non-executive member,
    1. Konstantinos P. Rozakeas, Executive member,
    1. Konstantinos F. Stamatiou, Executive member,
    1. Ioannis K. Bouras, Executive member,
    1. Georgios P. Kostianis, Executive member,
    1. Christos I. Oikonomou, Independent non-executive member,
    1. Nikolaos P. Nomikos, Independent non-executive member,
    1. Irene M. Nikiforaki, Independent non-executive member

The BoD's term is 5 years, that is until May 19th 2026, automatically extended until the end of the term, within which period the next regular general meeting must convene after the end of its term and until the relevant decision is taken, and it is not possible to exceed six years.

❖ Following the decision of the Annual General Meeting of the Company's Shareholders, which was held on May 20th, regarding the appointment of the Audit Committee, the Audit Committee was formed into body on May 28th 2021.

Following:

  • a) the election of the new third person, Mr. Ioannis Arkoulis of Michael, by the Ordinary General Meeting dated May 20th 2021, after having confirmed that the requirements set out by the provisions of article 44 of the L.4449/2017 are met, and
  • b) the appointment by the Board of Directors, of the independent and non-executive members of the Board of Directors, Ms. Irene M. Nikiforaki and Mr. Christos I. Economou, as the independent and non-executive members, who, together with Mr. I. Arkoulis, will form the Audit Committee, the aforementioned members of the Audit Committee, during the Committee's meeting on May 28th 2021, decided to appoint, Mr. Ioannis Arkoulis of Michael as its Chairman,
  • the Company's Audit Committee was formed as follows:
  • Ioannis M. Arkoulis, Chairman of the Audit Committee,
  • Christos I. Economou of Ioannis, member of the Audit Committee,
  • Irene M. Nikiforaki, member of the Audit Committee.

It is noted that the Audit Committee is an independent committee, since it consists of two independent nonexecutive members of the Board of Directors and a third person, and has a term starting from its election until the Ordinary General Meeting to be convened in 2022.

❖ Following the General Shareholders Meeting resolution dated May 20th 2021, the company GR. SARANTIS S.A. announced the distribution of dividend payment for the fiscal year 2020 amounting to 0.214661421 euro per share.

According to the legislation in force, the dividend corresponding to the company's 2,891,424 treasury shares was applied to the dividend paid out to the other shareholders and hence the dividend was increased to 0.22392718 euro per share.

The aforementioned dividend amount was subject to a 5% withholding tax and therefore shareholders received a net amount of 0,212730821 euro per share.

May 25th 2021 was set as the ex-dividend date, while the entitled shareholders were those registered in the Dematerialized Securities System on May 26th 2021 (Record date).

The dividend payment took place on May 31st 2021.

❖ On 26/05/2021, 10% of IVYBRIDGE was acquired by the Company, therefore the Group now owns 100% of both the direct participation of IVYBRIDGE, as well as the indirect participation in the subsidiaries ERGOPACK and HOZTORG.

The Group's response to COVID-19

The exponential COVID-19 spread and its declaration by WHO as a pandemic, is an unexpected global challenge with an uncertain course.

The Group responded with flexibility and sensitivity, supported by its people, despite the continuous challenges across the Group's countries.

Sarantis Group, with an utmost sense of responsibility, closely monitors the recent developments and responds appropriately at all levels, having prepared a specific coronavirus action plan, according to the evolution of the pandemic across its geographical region.

Since the beginning of the COVID-19 outbreak, set out its key priorities:

Ensuring the protection and safety of employees, customers, partners, consumers, as well as the ongoing support of social groups in need, especially those at the forefront of the pandemic and caring for those affected.

Since the beginning of 2020, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.

In Greece, a special coronavirus protection policy was enacted which includes remote working, suspension of both professional and personal travel, cancellation of both internal and external events, the headquarters' decontamination and special health guidance. In the other countries of its operation, the Group aligned with the precautionary measures taken by the authorities and implemented remote work and further specific protection measures.

Since then, the Group maintains safety and hygiene measures across its facilities and adapts according to the restrictive measures imposed by governments and relevant authorities in the countries of its operation, as the pandemic is still evolving.

In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries, through product and monetary donations, as well as donations in-kind to hospitals, nursing homes, NGOs and other socially vulnerable groups.

Moreover, during the quarantine period, we offered internally information on the pandemic and health & wellbeing promotion services [eg. healthy nutrition habits within the quarantine, alternative proposals of leisure entertainment like seminars, online theaters, online books, online tours, etc].

Implementing contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.

As the needs of the consumers turned to specific product categories, the Group ensured its ability to respond to increased demand for specific product categories, such as home care and personal hygiene products as well as food supplements.

In addition, the Group entered into the production of antibacterial products, in the hand cleansing category, in order to meet the high demand for these products.

Maintenance of financial resilience and implementation of the Group's strategic plan in order to support the Group's further growth.

Amidst this extraordinary environment, and as the Group's priorities remained focused on the health & safety of its employees and the society and its uninterrupted business continuity, the Group managed to maintain a solid

financial position and free cashflow generation, while executing its investment plan and creating further value to all stakeholders.

During the first half of 2021, investments realized relate to new product development, upgrading machinery equipment, expanding production capacity, while a dividend payment was done to the shareholders of the Company.

The Group's agility and ability to respond to unpredictable consumption trends, increased demand for certain product categories, and deal with unprecedent challenges posed by the COVID-19 crisis, is reflected in the Group's robust H1 2021 performance which is characterized by increased sales, increase in earnings and strong cashflow generation.

Specifically, the Group's turnover and net profit increased by 6.29% and 24.90%, respectively, in H1 2021 compared to the previous year's first half, and the Group's cash and cash equivalents amounted to € 23.2 million. The only activity affected during the first half of 2021 due to the pandemic is that of luxury cosmetics, as the clients of this channel were in lockdowns frequently throughout the year. Nevertheless, the increased consumption following the reopening of this channel resulted in luxury cosmetics sales growth of 3.28% and EBIT growth of 22.78% during the first half of 2021

Regarding the receivables from the luxury cosmetics customers, and although the extension of the check repayment to 75 days was used, until today there is a normal flow of collection.

Even though the operating environment across our region has improved within the first half of 2021, it still remains volatile, particularly considering the resurgence of COVID-19 cases and the rapid spread of the Delta variant. Occasional closures and restrictions will most likely continue within the year, affecting daily life and therefore consumption trends. Nevertheless, we are encouraged by our resilient performance within the first half of 2021, our strong financial position and cashflow generation, that provide safety and the support necessary to mitigate any potential negative impact arising from the pandemic. The management will stay focused on tits long-term goals in order to bring further top line growth, further improvement on profit margins and cashflow generation.

2.4 MAJOR RISKS AND UNCERTAINTIES FOR THE 2nd HALF OF 2021.

The Group is exposed to financial and other risks, including the unforeseen changes in interest rates, credit risks and liquidity risks. The Group's overall risk management program aims at minimizing the possible negative effects from such risks on its financial performance. The Group's financial instruments consist mainly of deposits with banks, trade accounts receivable and payable, loans and dividends payable.

2.4.1 Foreign exchange risk

The Group operates in an environment characterized by relatively high foreign exchange risk given that almost 65% of the Group's total turnover comes from Eastern European countries where the volatility of foreign exchange rates is likely to be high. The management of the Group is constantly examining the currencies' fluctuations, but at the moment it has not taken any measures against the foreign exchange risk due to the lack of appropriate hedging tools.

2.4.2 Interest rate risk

The interest rate risk emerges from the relation between the cost of debt and the subsequent effect of any interest rate changes on the earnings and cash flows. The Group's objective is to achieve an optimal balance between borrowing cost and the potential effect of any interest rate changes on earnings and cash flows. The Group monitors and manages its debt and overall financing strategies using a combination of short and long-term debt. It is policy of the Group to continuously review interest rate trends along with its financing needs. Daily working capital requirements are typically financed with operational cash flow and through the use of various committed lines of credit. The interest rate on these short-term borrowing arrangements, is generally determined as the inter-bank offering rate at the borrowing date plus a pre-set margin. The mix of fixed-rate debt and variable-rate debt is managed within Group policy guidelines.

2.4.3 Credit risk

Credit risk is the risk that a counterparty will cause the Group and the Company to suffer a financial loss because of the obligation to settle the liabilities. The maximum credit risk to which the Group and the Company are exposed at the date of the preparation of the financial statements is the book value of their financial assets.

Financial assets classified as at fair value through profit or loss are viewed not to expose the Group and the Company to material credit risk.

The greater part of the risk is found in the event that the debtor - customer of the Group may default on contractual obligations resulting in material loss to the Group. The Group's receivables come from wholesale, while a large part of its receivables come from large customers. The financial position of the customers is continuously monitored by the Group companies, which both control the amount of credit provisions and the credit limits of the accounts and, on the other hand, try to effectively manage the receivables before they become overdue but also when they become overdue or doubtful. Where necessary, additional collateral is required with guarantees.

In order to monitor credit risk, customers are grouped according to the category they belong to, their credit risk characteristics, the maturity of their receivables and any previous problematic receivables that they have demonstrated, taking into account future factors as well as the economic environment.

The Group and the Company apply the simplified approach of IFRS 9 for the calculation of expected credit losses and recognize impairment losses for expected credit losses for all financial assets other than those measured at fair value through profit or loss.

During the year and despite the COVID-19 pandemic, the flow of receivables from clients is normal, as the Group's main distribution network is the mass market channel, which remained in full and even increased operation due to increased consumer needs. In addition, the health care network was fully operational, which means that more than 90% of the Group's sales remain unaffected by operating suspensions.

Specifically, regarding customers who have used the 75-day check repayment extension, the Company still receives all receivables. These customers relate to the luxury cosmetics network in Greece, which is periodically suspended, while the sales of this network represent less than 10% of the total sales of the Group.

2.4.4 Liquidity risk

The liquidity risk refers to a case when the Group is not in position to fulfill its obligations with regard to money payments. Prudent liquidity risk management implies the existence of a balance between cash flows as well as funding through adequate amounts of committed credit facilities. The Group closely monitors the amount of funding as well as the short-term and long-term funding with respect to total debt and the composition of total debt, and it manages the risk that could arise from the lack of sufficient liquidity and secures that necessary borrowing facilities are maintained. The Group has sufficient credit line facilities that could be utilized to fund any potential shortfall in cash resources.

The Group manages and monitors its working capital in order to minimize any possible liquidity and cash flow risks.

2.4.5 Raw material price risk

The Group is exposed to price volatility in the basic raw materials it uses for products that manufactures in its own production facilities.

❖ The basic raw materials used by the Group for the Perfume, Cosmetics and Face Care products are perfumes, oils and chemicals.

The prices of raw materials in perfumes, cosmetics and facials present fluctuations, and any differences are eliminated by gradually transferring volumes from one supplier to another when necessary, maintaining active alternative suppliers and creating security stocks.

❖ The basic raw materials used by the Group for the categories of household products (food packaging products and plastic waste bags) are aluminum (in jumbo rolls), plastic (PVC / LDPE Clingfilm in Jumbo rolls) and polyethylene (HDPE, LDPE, LLDPE).

Regarding the effect of fluctuations in the prices of aluminum and plastic, the Group proceeds to the closing of price at short intervals, and in addition creates a security stock when it deems it necessary.

2.4.6 Compliance Risk

The incomplete compliance with the legal regulatory framework that governs the Group could lead to penalties and other fines, so by this way it will negatively affect the financial position and, as a result its reputation. Regulatory compliance issues that are recognized by the management are as follows:

  1. Issues related to commercial legislation

  2. Taxation and labor issues

  3. Issues related to the Capital Market Committee and the Stock Exchange

  4. Issues related to the protection of personal data

  5. Issues covered by the Code of Ethics (fraud, bribery, child labor, work safety and work practices, issues relating to free competition, etc.)

  6. Issues relating to the protection of the environment and the operation of the production facilities.

  7. Issues relating to product safety and certification (e.g. EFET) where provided, as well as to the protection of consumers.

The relevant body that is responsible for assessing the risks is the Execution Committee. Each group of risks shall be examined separately. The likelihood of occurrence, the potential effect and the level of the organization's abundance are estimated, and then the optimum actions are being proposed. Subsequently the Group assigns the personnel responsible for the management who implement the agreed actions and inform the administration about the results of these actions.

2.4.7 Pandemic Crisis of COVID

The COVID-19 pandemic has led to an unprecedented crisis in global health and the economy. The Group responded immediately at all levels, through a specific coronavirus action plan, in accordance with the evolution of the pandemic across its geographical region.

Since the beginning of the COVID-19 outbreak, the Group had set out its key priorities concerning the health & safety of its employees and the society, the uninterrupted business continuity and the continuous supply of high-demand products to the market.

Since the beginning of 2020, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.

In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries.

The Group implemented contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.

While the outlook for the global economy in 2021 remains uncertain and the vaccination process is in process, the management is encouraged by the Group's resilient performance, its strong financial position and cashflow generation.

Furthermore, the Group's basic distribution channel is the mass retail market has remained in full operation throughout this period.

The Group's strong capital base, low net debt and strong cash flows, provide safety and the support necessary to mitigate any potential negative impact, enabling it to continue as a going concern.

2.5 FUTURE OUTLOOK AND PROSPECTS

Even though the operating environment across our region has improved within the first half of 2021, it still remains volatile, particularly considering the resurgence of COVID-19 cases and the rapid spread of the Delta variant. Occasional closures and restrictions will most likely continue within the year, affecting daily life and therefore consumption trends.

Nevertheless, the Group's resilient performance within the first half of 2021, itsstrong financial position and cashflow generation, provide safety and the support necessary to mitigate any potential negative impact arising from the pandemic.

Within this context, the management will continue to pursue its long-term goals in order to bring further top line growth, further improvement on profit margins and cashflow generation, supporting this way the business and returning value to its shareholders. The Group's strategy remains unchanged with the focus being, as always, on

organic and acquisitive growth, new strategic partnerships, geographical expansion, cost efficiencies, economies of scale, benefits from synergies and operating leverage.

Throughout this period, and until a gradual return to normality is achieved, the management's priorities will continue to concern the health and safety of the Group's employees and the society, the uninterrupted business continuity and continuous supply of high-demand products to the market, and the maintenance of a strong financial position.

The Group's strong financial performance is giving the management drive to continue playing an active role towards supporting the local communities, addressing emerging societal needs, particularly relating to COVID-19, and operating in an environmentally responsible way, as the Group's ultimate aim is to maintain the optimum balance between its economic performance and its responsible environmental and social practices.

The further development of the Group's sustainability strategy is amongst the top priorities of the Group's newly elected Board of Directors, addressing its four main pillars: sustainable production and consumption, responsible governance, empowered employees and thriving communities.

Business practices such as creating employment, investing in human capital development, safeguarding occupational health, safety and well-being, improving consumers health & well-being, minimizing greenhouse gas emissions, enhancing sustainable sourcing and improving waste management are amongst the areas where the Group will intensify its efforts in order to maximize the positive economic, social and environmental impacts of its operation.

2.6 RELATED PARTY TRANSACTIONS

The most significant transactions between the Company and its related parties, as such are defined by International Accounting Standard 24, are presented below.

Subsidiaries Company
Trade receivables 30.06.2021 31.12.2020
Sarantis Belgrade D.O.O 39,750 88,281
Sarantis Banja Luca DOO 0 197
Sarantis Skopje D.O.O 0 245
Sarantis Bulgaria LTD 157,023 153,617
Sarantis Romania S.A. 799,271 582,200
Sarantis Polska S.A. 884,047 723,296
Sarantis Czech Republic sro 1,297,134 1,422,939
Polipak SP.Z.O.O. 6,414 47,530
Sarantis Slovakia S.R.O 156,089 320,150
Ergopack LLC 1,092,792 1,108,875
Sarantis Hungary Kft. 113,218 303,954
Sarantis Portugal Lda 595,831 1,119,722
Elode France SARL 28,480 27,734
Total 5,170,050 5,898,740
Trade Liabilities 30.06.2021 31.12.2020
Sarantis Belgrade D.O.O 2,020,204 1,067,589
Sarantis Banja Luca DOO 4,251 5,648
Sarantis Skopje D.O.O 1,033,479 301,140
Sarantis Bulgaria LTD 17,108 0
Sarantis Romania S.A. 80,748 10,687
Sarantis Polska S.A. 425,791 629,875
Sarantis Czech Republic sro 18,525 0
Polipak SP.Z.O.O. 753,921 321,052
Sarantis Slovakia S.R.O 4,252 0
Ergopack LLC 61,699 470
Sarantis Hungary Kft. 11,532 10,626
Sarantis Portugal Lda 744 0
Sarantis France SARL 48,200 48,960
Total 4,480,454 2,396,047
Liabilities from loans 30.06.2021 31.12.2020
Sarantis Bulgaria LTD 6,751,855 7,501,237
Sarantis Romania S.A. 13,503,711 15,002,474
Sarantis Polska S.A. 6,751,855 7,501,237
Waldeck LTD 559,194 558,255
Total 27,566,616 30,563,203

Grand Total Liabilities 32,047,069 32,959,250

Income

Income from sale of merchandise 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 1,004,745 1,353,981
Sarantis Skopje D.O.O 267,476 358,324
Sarantis Bulgaria LTD 845,471 968,681
Sarantis Romania S.A. 2,883,377 3,645,733
Sarantis Polska S.A. 3,927,582 3,904,976
Sarantis Czech Republic sro 2,279,745 1,658,030
Sarantis Slovakia S.R.O 929,323 428,420
Ergopack LLC 529,042 662,119
Sarantis Hungary Kft. 244,492 331,088
Sarantis Portugal Lda 355,733 387,868
Total 13,266,985 13,699,221
Income – Interest 01.01 - 30.06.2021 01.01 - 30.06.2020
Ergopack LLC 0 53,849
Total 0 53,849
Other Income 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 88,953 99,059
Sarantis Banja Luca DOO 4,251 2,249
Sarantis Skopje D.O.O 10,772 9,018
Sarantis Bulgaria LTD 17,481 11,727
Sarantis Romania S.A. 41,791 41,038
Sarantis Polska S.A. 264,445 122,452
Sarantis Czech Republic sro 74,123 38,905
Polipak SP.Z.O.O. 30,716 14,345
Sarantis Slovakia S.R.O 31,406 13,938
Ergopack LLC 78,581 120,705
Sarantis Hungary Kft. 31,727 39,188
Sarantis Portugal Lda 27,081 32,609
Total 701,328 545,234
Grand Total Income 13,968,314 14,298,303

Expenses and Purchases

Purchases of Merchandise - Services 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 0 6,938
Sarantis Romania S.A. 49,732 7,355
Sarantis Polska S.A. 868,115 877,614
Sarantis Czech Republic sro 399 6,829
Polipak SP.Z.O.O. 1,491,492 2,056,495
Sarantis Slovakia S.R.O 1,424 0
Ergopack LLC 0 2,736
Total 2,411,162 2,957,967
Expenses – Interest 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Bulgaria LTD 70,626 93,844
Sarantis Romania S.A. 141,251 188,006
Sarantis Polska S.A. 70,626 94,279
Waldeck LTD 10,939 11,000
Total 293,441 387,128
Grand Total Expenses 2,704,603 3,345,094
Table of Disclosures of Related Parties
Group
Company
a) Income 0 13,968,314
b) Expenses 0 2,704,603
c) Receivables 0 5,170,050
d) Liabilities 0 32,047,069
e) Transactions and remuneration of senior executives and management 1,686,693 1,686,693
f) Receivables from senior executives and management 84,778 84,778
g) Liabilities towards senior executives and management 0 0
h) Receivables from affiliates 178 178
i) Liabilities to affiliates 0 0

2.7 Information concerning the acquired Treasury Shares according to article 50, paragraph 2, Law 4548/2018.

During the first half of 2021, the Company proceeded to the purchase of 67,429 treasury shares at an average purchase price of 8.96 euro per share, paying 604,210 euro.

Including the 2,825,995 treasury shares already held by the company as of 31/12/2021, the Company holds in total 2,893,424 treasury shares with nominal value of EUR 0.78 per share and an average purchase price of 4.82 euro per share, having paid a total of 13,934,604 euro.

The treasury shares that the Company holds correspond to 4.14% of its share capital.

2.8 SUBSEQUENT EVENTS

  • The Group announced on July 8th 2021 that, in accordance with the terms and conditions of the amended Shareholders Agreement entered into with Estee Lauder Europe, Inc. ("EL Europe") with respect to the company ELCA Cosmetics Limited ("ELCA"), EL Europe provided the first call option notice for the purchase of shares held by the Group. The first call option represents 9% of ELCA's shares.

ELCA is a joint venture that was created in 2001 for the sale and distribution of beauty products in Greece, Romania, Bulgaria and Cyprus. ELCA is currently owned by Sarantis Group, which holds a 49% interest in the joint venture and EL Europe which holds the remaining 51% interest.

ELCA is based in Cyprus and fully owns the subsidiary companies ESTEE LAUDER HELLAS S.A. Cosmetics Distribution, ΕSTEE LAUDER BULGARIA EOOD and ESTEE LAUDER ROMANIA Srl., based in Greece, Bulgaria and Romania respectively.

Based on the amended Shareholders Agreement, EL Europe has the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, including the right to increase its stake based on the financial statements of ELCA at June 30th 2021, June 30th 2024 and June 30th 2027 for 9%, 25% and 15% respectively.

The Group's strategy with respect to ELCA remains unchanged and is based on two factors:

1) utilizing the liquidity that will be created during the period 2021-2027 behind acquisitions that satisfy the Group's criteria and are able to provide synergies and contribute to profitability;

2) absorbing new distribution agreements that will further strengthen the Group's product portfolio.

As always, the management's goal is to execute its investment plan, focusing on its strategic product categories, geographical expansion and cost efficiencies, ultimately creating further value to its shareholders.

❖ During July 16th 2021, the Extraordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the sole item on the agenda being the approval of the Suitability Policy for the BoD members according to article 3. paragraph 3 of the law 4706/2020.

Read the resolutions of the Extraordinary General Shareholders Meeting of July 16th 2021.

2.9 ALTERNATIVE PERFORMANCE MEASURES ("APMs")

The Group utilizes Alternative Performance Measures (APM) in the context of its decision making with regard to the financial, operational and strategic planning as well as for the evaluation and public disclosure of its performance. These APMs serve and facilitate the best understanding of the financial and operating results of the Group, its financial position and the statement of cash flows. The Alternative Performance Measures (APMs) should be always taken into consideration along with the financial results which have been prepared in accordance with the IFRS whereas in no case they replace IFRS.

Definitions and reconciliation of Alternative Performance Measures ("APM")

a) Profitability ratios

The Group utilizes the following profitability ratios for the purpose of the full analysis of its operating results:

EBITDA (Earnings before interest, taxes, depreciation and amortization)

EBITDA is calculated from the annual financial statements as follows: "Gross operating earnings" plus "Other operating income" minus the "Administrative Expenses" and the "Distribution Expenses" prior to depreciation and amortization. The depreciation and amortization for the Group are presented in the paragraph "Table of Changes in Fixed Assets" of the financial statements.

(Euro million) H1 2021 H1 2020
Gross operating earnings 73.20 68.01
Other operating income 6.64 5.85
Administrative expenses 9.73 9.29
Distribution expenses 45.21 42.31
Depreciation and amortization 6.42 6.18
Earnings before interest, taxes,
depreciation and amortization
31.32 28.44

EBIT (Earnings before interest and taxes)

EBIT equals with the operating earnings of the Group as they are recorded in the annual financial statements.

ΕΒΤ (Earnings before taxes)

EBT equals with the earnings deriving before the deduction of taxes from the annual financial statements.

Net Income (Net earnings)

It equals with the earnings after the deduction of taxes as they are recorded in the financial statements. These earnings are distributed to the shareholders of the parent company.

Profitability Margins

For all the above profitability figures, the corresponding profit margin is calculated by dividing each figure with the total turnover.

(Euro million) H1 2021
Margin
H1 2020
Margin
EBITDA Earnings before interest, taxes,
depreciation and amortization
31.32 16.04% 28.44 15.48%
EBIT Earnings before interest and taxes 24.90 12.75% 22.26 12.12%
EBT Earnings before taxes 24.71 12.66% 19.63 10.69%
Net Income Net Earnings 19.51 9.99% 15.62 8.50%

b) Net Debt

The net debt comprises a figure which depicts the capital structure of the Group. It is calculated by adding the longterm loans and the short-term loans then by deducting the cash and cash equivalents and other financial assets, such as the "Financial Assets at fair value through results", since they are considered to be liquid items. The relevant calculations are presented in the following table:

(Euro million) H1 2021 FY 2020
Long-term loans 50.92 48.61
Short-term loans 13.86 7.81
Cash and cash equivalents 23.19 40.60
Other financial assets 6.21 4.91
Net Debt 35.38 10.91

Marousi, September 8 th 2021

The Board of Directors

THE CHAIRMAN OF THE BOARD MANAGING DIRECTOR THE GROUP'S CHIEF FINANCIAL OFFICER & BOARD MEMBER

GRIGORIS SARANTIS KYRIAKOS SARANTIS KONSTANTINOS ROZAKEAS

ID NO. Χ 080619/03 ID NO. ΑΙ 597050/2010 ID NO. ΑΚ 783631/13

3. REPORT ON REVIEW OF THE INTERIM FINANCIAL INFORMATION

To the Board of Directors of "GR. SARANTIS S.A."

Introduction

We have reviewed the accompanying interim condensed separate and consolidated statement of financial position of "GR. SARANTIS S.A." as at 30 June 2021 and the related condensed separate and consolidated statements of comprehensive income, changes in equity and cash flows for the six-month period then ended, as well as the selected explanatory notes that comprise the interim condensed financial information, which is an integral part of the six-month financial report as required by the Law 3556/2007.

Management is responsible for the preparation and presentation of this interim condensed financial information in accordance with the International Financial Reporting Standards as adopted by the European Union and applied to Interim Financial Reporting (International Accounting Standard "IAS 34"). Our responsibility is to express a conclusion on this interim condensed financial information based on our review.

Scope of Review

We conducted our review in accordance with International Standard on Review Engagements 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing, as incorporated into the Greek Legislation and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim condensed financial information is not prepared, in all material respects, in accordance with IAS 34.

Report on other legal and regulatory requirements

Our review has not revealed any material inconsistency or misstatement in the statements of the members of the Board of Directors and the information of the six-month Board of Directors Report, as defined in articles 5 and 5a of Law 3556/2007, in relation to the accompanying interim condensed financial information.

BDO Certified Public Accountant S.A. 449 Mesogion Av, Athens- Ag. Paraskevi, Greece Reg. SOEL: 173

Ag. Paraskevi, September 9, 2021 Certified Public Accountant

Christoforos I. Achiniotis Reg. SOEL: 35961

4. INTERIM CONDENSED FINANCIAL STATEMENTS

Those responsible for the preparation of the Interim Financial Statements of the period 01/01 – 30/06/2021 are the signatories at the end of the Financial Statements.

4.1 STATEMENT OF FINANCIAL POSITION

Group
Note
Company
Amounts in € 30.06.2021 31.12.2020 30.06.2021 31.12.2020
ASSETS
Non-current assets 195,092,031 183,401,276 185,434,234 181,918,424
Tangible fixed assets 4.9.17 87,298,505 73,343,011 40,862,048 38,791,337
Right of use 4.9.17 12,575,819 14,622,686 4,850,297 5,694,264
Investments in Property 4.9.17 1,021,382 1,033,026 31,857 31,857
Intangible assets 4.9.17 59,683,415 60,381,322 30,758,887 31,436,048
Company goodwill 4.9.3 7,701,262 7,676,364 1,100,000 1,100,000
Deferred tax assets 1,217,512 287,378 0 0
Investments in subsidiaries, associates 4.9.2 25,254,899 25,649,283 107,608,517 104,633,691
Other long-term receivables 339,237 408,207 222,628 231,228
Current assets 244,927,997 251,973,162 117,054,362 119,516,988
Inventories 4.9.4 107,998,681 108,595,399 46,670,984 49,258,450
Trade receivables 4.9.5 99,879,902 90,951,747 51,393,588 45,583,265
Other receivables 4.9.5 7,652,298 6,921,480 6,614,773 3,628,334
Cash & cash equivalents 4.9.6 23,186,916 40,595,341 6,164,817 16,137,744
Financial assets at fair value through profit and loss 4.9.7 6,210,201 4,909,195 6,210,201 4,909,195
Total Assets 440,020,029 435,374,438 302,488,596 301,435,412
Shareholders' EQUITY:
Share capital 4.9.13 54,504,437 54,504,438 54,504,438 54,504,438
Share premium account 40,676,356 40,676,356 40,676,356 40,676,356
Reserves 17,783,176 17,463,998 126,450,525 141,131,347
Profit (losses) carried forward 161,229,141 157,236,105 (14,433,748) (33,598,025)
Amounts attributed for Capital Increase
Total Shareholders' Equity 274,193,110 269,880,896 207,197,569 202,714,115
Non controlling interest 1,996,815 2,638,737 0 0
Total Equity 276,189,925 272,519,633 207,197,569 202,714,115
LIABILITIES
Long-term liabilities 68,879,839 70,635,943 46,732,803 52,619,959
Loans 4.9.10 48,413,329 48,607,624 38,496,250 44,000,000
Lease liabilities 8,601,116 10,595,268 3,190,104 3,974,856
Deferred tax liabilities 5,989,671 5,642,981 2,205,342 1,812,104
Provisions for post employment employee benefits 2,970,203 2,953,256 2,841,107 2,825,911
Provisions - Long-term liabilities 4.9.9 2,905,520 2,836,813 0 7,087
Short-term liabilities 94,950,264 92,218,863 48,558,223 46,101,339
Suppliers 4.9.8 52,779,295 64,800,497 24,280,172 29,662,690
Other liabilities 4.9.8 12,962,757 9,220,899 9,914,646 6,048,675
Income taxes - other taxes payable 8,438,481 5,745,599 4,120,584 2,499,440
Loans 4.9.10 16,367,034 7,805,390 8,503,750 6,000,000
Lease liabilities 4,402,698 4,646,478 1,739,072 1,890,534
Total Equity & Liabilities 440,020,029 435,374,438 302,488,596 301,435,412

4.2 INTERIM CONDENSED ITEMS OF THE STATEMENT OF INCOME

Group Company
Note 01.01-30.06.2021 01.01-30.06.2020 01.01-30.06.2021 01.01-30.06.2020
Amounts in € Total Activities Total Activities Total Activities Total Activities
Revenue 4.9.1 195,235,968 183,688,988 82,512,885 81,334,988
Cost of sales (122,036,362) (115,675,810) (50,616,526) (52,080,625)
Gross operating profit 73,199,605 68,013,177 31,896,360 29,254,363
Income from associates 6,348,113 5,150,596 0 0
Other operating income 292,448 699,176 796,768 845,292
Administrative expenses (9,725,048) (9,294,959) (5,347,191) (4,779,001)
Distribution expenses (45,213,870) (42,310,438) (22,500,501) (21,534,697)
Operating profit (loss) 24,901,249 22,257,551 4,845,435 3,785,957
Financial Income-Expenses 4.9.12 (190,031) (2,640,221) 16,442,837 6,115,244
Gain (loss) from revaluation of fixed assets 0 12,360 0 0
Earnings (loss) before taxes 24,711,218 19,629,690 21,288,272 9,901,200
Income tax 4.9.11 (5,551,973) (5,165,571) (807,370) (947,812)
Deferred tax 4.9.11 596,426 1,525,993 (402,286) 368,823
Earnings (loss) after the deduction of tax (A) 19,755,671 15,990,112 20,078,616 9,322,212
Owners of the parent 19,506,183 15,617,534 20,078,616 9,322,212
Non controlling interest 249,488 372,578 0 0
Other Comprehensive Income: 0 0 0 0
Items not transferred to the statement of
comprehensive income:
9,049 7,453 9,049 7,453
Profit/Loss from actuarial study 0 9,806 0 9,806
Actuarial study deferred tax 0 (2,354) 0 (2,354)
Effect from change in tax rate 9,049 0 9,049 0
Items which may be transferred in future to the
statement of comprehensive income:
2,484,609 (4,603,458) 0 0
Foreign exchange differences from subsidiaries abroad 2,484,609 (4,603,458) 0 0
Other total income after taxes (Β) 2,493,658 (4,596,005) 9,049 7,453
Total comprehensive income after taxes (A) + (B) 22,249,329 11,394,107 20,087,665 9,329,665
Owners of the parent 21,891,834 11,256,267 20,087,665 9,329,665
Non controlling interest 357,495 137,840 0 0
Earnings (loss) per share, which correspond to the
parent's shareholders for the period
4.9.14 0.2912 0.2326 0.2997 0.1388

4.3 INTERIM CONDENSED STATEMENT OF CHANGES IN GROUP'S EQUITY FOR THE PERIOD

Amounts in € Share Capital Share Premium Readjustments Reserve
and other reservesl
Balance of profit /
losses
Total Non controlling
interest
Total
Balance as at 1 January 2020 54,504,438 40,676,356 13,751,423 142,339,550 251,271,767 2,364,554 253,636,320
Total comprehensive income for the period
Net profit for the period 15,617,534 15,617,534 372,578 15,990,112
Other comprehensive income
Foreign exchange differences (4,368,720) (4,368,720) (234,738) (4,603,458)
Reserve due to actuarial study 7,453 7,453 7,453
Change from associates
Other comprehensive income 7,453 (4,368,720) (4,361,268) (234,738) (4,596,006)
Other transactions registered in Equity
Total comprehensive income after taxes 7,453 11,248,813 11,256,266 137,840 11,394,107
Purchase of treasury shares (81,929) (81,929) (81,929)
Distributed dividends (11,214,034) (11,214,034) (11,214,034)
Formation of reserves 3,989,277 (3,989,277) 0 0
Change from associates (90,577) (90,577) (90,577)
Other transactions registered in Equity 0 0 3,907,348 (15,293,889) (11,386,541) (11,386,541)
Balance as at 30 June 2020 54,504,438 40,676,356 17,666,224 138,294,476 251,141,493 2,502,394 253,643,887
Balance as at 1 January 2021 54,504,437 40,676,356 17,463,998 157,236,104 269,880,895 2,638,737 272,519,632
Total comprehensive income for the period
Net profit for the period 19,506,183 19,506,183 249,488 19,755,671
Other comprehensive income
Foreign exchange differences 2,376,602 2,376,602 108,007 2,484,609
Reserve due to actuarial study 9,049 9,049 9,049
Other comprehensive income 9,049 2,376,602 2,385,650 108,007 2,493,658
Other transactions registered in Equity
Total comprehensive income after taxes 9,049 21,882,785 21,891,834 357,495 22,249,329
Purchase of treasury shares (604,210) (604,210) (604,210)
Distributed dividends (15,000,000) (15,000,000) (15,000,000)
Minority interests due to acquisition of interest in a subsidiary (1,975,409) (1,975,409) (999,417) (2,974,826)
Formation of reserves 914,339 (914,339) 0 0
Other transactions registered in Equity 310,129 (17,889,749) (17,579,619) (999,417) (18,579,036)
Balance as at 30 June 2021 54,504,437 40,676,356 17,783,176 161,229,141 274,193,110 1,996,815 276,189,925

4.4 INTERIM CONDENSED STATEMENT OF CHANGES IN COMPANY'S EQUITY FOR THE PERIOD

Attributed to shareholders of the parent
Amounts in € Share Capital Share Premium Readjustments Reserve
and other reservesl
Balance of profit /
losses
Total
Balance as at 1 January 2020 54,504,438 40,676,356 137,114,752 (35,743,113) 196,552,433
Total comprehensive income for the period
Net profit for the period 9,322,212 9,322,212
Other comprehensive income
Reserve due to actuarial study 7,453 7,453
Other comprehensive income 7,453 7,453
Other transactions registered in Equity
Total comprehensive income after taxes 7,453 9,322,212 9,329,665
Purchase of treasury shares (81,929) (81,929)
Formation of reserves 3,898,794 (3,898,794) 0
Distributed dividends (11,214,034) (11,214,034)
Other transactions registered in Equity (7,397,170) (3,898,794) (11,295,964)
Balance as at 30 June 2020 54,504,438 40,676,356 129,725,035 (30,319,695) 194,586,134
Balance as at 1 January 2021 54,504,438 40,676,356 141,131,347 (33,598,025) 202,714,115
Total comprehensive income for the period
Net profit for the period 20,078,616 20,078,616
Other comprehensive income
Reserve due to actuarial study 9,049 9,049
Other comprehensive income 9,049 9,049
Other transactions registered in Equity
Total comprehensive income after taxes 9,049 20,078,616 20,087,665
Purchase of treasury shares (604,210) (604,210)
Distributed dividends (15,000,000) (15,000,000)
Formation of reserves 914,339 (914,339) 0
Other transactions registered in Equity (14,689,871) (914,339) (15,604,210)
Balance as at 30 June 2021 54,504,438 40,676,356 126,450,525 (14,433,748) 207,197,569

4.5 INTERIM CONDENSED STATEMENT OF CASH FLOWS

Group Company
Amounts in € 01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020
Operating Activities
Earnings / (loss) before tax (continuing activities) 24,711,218 19,629,690 21,288,272 9,901,200
Plus/minus adjustments for:
Depreciation/Amortization 6,418,410 6,180,538 3,405,400 3,320,268
Revaluation of fixed assets 0 (12,360) 0 0
Foreign Exchange differences 120,312 1,174,488 (13,047) (37,912)
Results (income, expenses, profits and losses) from investing activities (7,362,375) (4,535,835) (17,325,565) (6,945,948)
Interest expense and related expenses 910,184 1,063,235 645,771 746,796
Decrease / (increase) in inventories 1,574,030 (15,587,470) 2,587,466 (4,774,445)
Decrease / (increase) in receivables (8,822,547) (881,515) (7,317,499) (1,836,715)
Decrease) / increase in liabilities (other than to banks) (6,662,756) 1,951,773 (1,147,240) 5,799,078
Less:
Interest and related expenses paid (729,727) (1,011,334) (584,375) (756,594)
Tax paid (3,009,608) (1,253,018) 0 0
Total inflows / (outflows) from operating activities (a) 7,147,141 6,718,194 1,539,185 5,415,730
Investing Activities
Acquisition/Sale of subsidiaries, associates, joint ventures and other investments (3,576,988) (1,909,118) (3,568,769) (9,393,960)
Purchase of tangible and intangible fixed assets (16,756,147) (17,626,841) (3,920,440) (13,603,372)
Proceeds from sale of tangible and intangible assets 126,806 96,569 58,002 5
6
Interest received 77,634 41,568 104,745 630,052
Dividends received 5,253,323 2,940,005 14,967,688 12,258,250
Proceeds from grants (201,241) 787,366 0 0
Total inflows / (outflows) from investing activities (b) (15,076,613) (15,670,451) 7,641,227 (10,108,973)
Financing Activities
Proceeds from loans granted / assumed 23,184,426 31,234,192 12,000,000 30,000,000
Payment of borrowings (15,000,000) (28,971,356) (15,000,000) (25,000,000)
Payment of lease liabilities (2,312,329) (1,968,545) (886,137) (847,587)
(Payments) / Proceeds from (purchase) / sale of treasury shares (604,210) (81,929) (604,210) (81,929)
Dividends paid towards the shareholders of the parent (14,662,991) (10,946,094) (14,662,991) (10,946,094)
Total inflows / (outflows) from financing activities (c) (9,395,104) (10,733,733) (19,153,338) (6,875,611)
Net increase / (decrease) in cash and cash equivalents (a+b+c) (17,324,576) (19,685,990) (9,972,927) (11,568,854)
Cash and cash equivalents at beginning of period 40,595,341 54,847,405 16,137,744 30,278,899
Effect from foreign exchange differences due to translation to euro (83,850) (677,084) 0 0
Cash and cash equivalents at the end of the period 23,186,916 34,484,332 6,164,817 18,710,045

4.6 NOTES ON THE INTERIM CONDENSED FINANCIAL STATEMENTS

4.6.1 The Company

Gr. Sarantis SA (the Company) has the legal form of a société anonyme and is the parent company of the Gr. Sarantis SA group (the group).

The Company's headquarters is located at 26 Amarousiou – Chalandriou Street, Marousi Greece, The Company's central offices are also located at the same address.

The shares of Gr. Sarantis SA are listed on the main market of the Athens Exchange.

4.6.2 Group Structure

The Group's companies, which are included in the consolidated financial statements, are the following:

GROUP STRUCTURE
Company Domicile Direct Participation
Percentage
Indirect Participation
Percentage
Total
GR. SARANTIS S.A. GREECE PARENT
SARANTIS BULGARIA LTD BULGARIA 100.00% 0.00% 100.00%
SARANTIS ROMANIA S.A. ROMANIA 100.00% 0.00% 100.00%
SARANTIS BELGRADE D.O.O. SERBIA 100.00% 0.00% 100.00%
SARANTIS BANJA LUKA D.O.O. BOSNIA 0.00% 100.00% 100.00%
SARANTIS SKOPJE D.O.O. F.Y.R.O.M. 0.00% 100.00% 100.00%
SARANTIS POLSKA S.A. POLAND 100.00% 0.00% 100.00%
POLIPAK SP. Z.O.O. POLAND 0.00% 80.00% 80.00%
SARANTIS CZECH REPUBLIC sro CZECH REPUBLIC 100.00% 0.00% 100.00%
SARANTIS HUNGARY Kft. HUNGARY 100.00% 0.00% 100.00%
ZETAFIN LTD CYPRUS 100.00% 0.00% 100.00%
ZETA COSMETICS LTD CYPRUS 0.00% 100.00% 100.00%
WALDECK LTD CYPRUS 0.00% 100.00% 100.00%
ELODE FRANCE S.A.R.L FRANCE 100.00% 0.00% 100.00%
SARANTIS FRANCE S.A.R.L FRANCE 100.00% 0.00% 100.00%
SARANTIS PORTUGAL Lda PORTUGAL 100.00% 0.00% 100.00%
ASTRID T.M. A.S. CZECH REPUBLIC 100.00% 0.00% 100.00%
SARANTIS SLOVAKIA S.R.O SLOVAKIA 0.00% 100.00% 100.00%
IVYBRIDGE VENTURES LTD CYPRUS 100.00% 0.00% 100.00%
SARANTIS UKRAINE LLC UKRAINE 100.00% 0.00% 100.00%
ERGOPACK LLC UKRAINE 0.00% 100.00% 100.00%
HOZTORG LLC RUSSIA 0.00% 100.00% 100.00%
Equity Consolidation Method
ELCA COSMETICS LTD CYPRUS 0.00% 49.00% 49.00%
ESTEE LAUDER HELLAS S.A. GREECE 0.00% 49.00% 49.00%
ΕSTEE LAUDER BULGARIA EOOD BULGARIA 0.00% 49.00% 49.00%
ESTEE LAUDER ROMANIA S.A. ROMANIA 0.00% 49.00% 49.00%
s

On 26/05/2021, 10% of IVYBRIDGE was acquired by the Company, and therefore the Group now owns 100% of both the direct participation of IVYBRIDGE, as well as the indirect participation of the subsidiaries ERGOPACK and HOZTORG.

Business Activity

The Group is active in the production and trade of cosmetics, household products and parapharmaceutical items.

The Group's basic activities have not changed since the previous year.

4.7 BASIS FOR THE PREPARATION OF THE FINANCIAL STATEMENTS

4.7.1 Compliance with IFRS

The consolidated and separate financial statements of "GR. SARANTIS S.A." are in accordance with the International Financial Reporting Standards (IFRS), which have been issued by the International Accounting Standards Board (IASB) as well as their interpretations which have been issued by the International Financial Reporting Interpretations Committee (IFRIC) of IASB and have been adopted by the European Union.

4.7.2 Basis for the preparation of the financial statements

The interim consolidated financial statements for the period ended on 30th June 2020, have been prepared in accordance with IAS 34 "Interim Financial Reporting". The financial statements do not include all disclosures that would otherwise be required in a complete set of annual financial statements and should be read in conjunction with the financial statements of the Company and the Group as of 31st December 2020. The latter are available at the Company's website www.sarantisgroup.com .

4.7.3 Approval of financial statements

The interim consolidated financial statements have been approved by the Company's Board of Directors on September 8 th 2021.

4.7.4 Covered Period

The present interim consolidated financial statements include the financial statements of "GR. SARANTIS S.A." and its subsidiaries, which together are referred to as the group, and cover the period from January 1st 2021 to June 30th 2021.

4.7.5 Presentation of the financial statements

The present financial statements are presented in €, which is the group's operating currency, namely the currency of the primary economic environment in which the parent company operates.

4.7.6 Significant judgments and estimations by Management

The preparation of the Financial Statements according to the International Accounting Standards requires the implementation of estimations, judgments and assumptions that may affect the accounting balances of assets and liabilities and the required disclosures for contingent receivables and liabilities, as well as the amount of income and expenses recognized.

During the preparation of the current interim condensed financial statements, the significant accounting judgments and estimations that were adopted by the Management in the application of the Group's accounting policies, as well as the major sources for estimation of the uncertainty, remained unchanged as compared to the ones applied in the annual financial statements of 31st December 2020, except for those that concern the adoption of the new IFRS that were set in effect on 1st January 2021 (see note 4.7.7).

Estimates on the impact of the COVID-19 on the Group's results

Sarantis Group, with an utmost sense of responsibility, closely monitors the recent developments and responds appropriately at all levels, having prepared a specific coronavirus action plan, according to the evolution of the pandemic across its geographical region.

The Group responded with great flexibility and sensitivity, supported by its people, although the continuous challenges throughout the countries of its activity.

Since the beginning of the COVID-19 outbreak, set out its key priorities:

Ensuring the protection and safety of employees, customers, partners, consumers, as well as the ongoing support of social groups in need, especially those at the forefront of the pandemic and caring for those affected.

Since the beginning of the pandemic, when the virus started to spread worldwide, the Group enacted a special management team and precautionary measures in line with each state's government in which it operates and in accordance with the official WHO's guidelines.

In Greece, a special coronavirus protection policy was enacted which includes remote working, suspension of both professional and personal travel, cancellation of both internal and external events, the headquarters' decontamination and special health guidance. In the other countries of its operation, the Group aligned with the precautionary measures taken by the authorities and implemented remote work and further specific protection measures.

Since then, the Group maintains safety and hygiene measures across its facilities and adapts according to the restrictive measures imposed by governments and relevant authorities in the countries of its operation, as the pandemic is still evolving.

In addition, the Group's contribution to the society was intensified during the pandemic, focusing on strengthening the health sector and supporting those in need in the Group's countries, through product and monetary donations, as well as donations in-kind to hospitals, nursing homes, NGOs and other socially vulnerable groups.

Moreover, during the quarantine period, we offered internally information on the pandemic and health & wellbeing promotion services [eg. healthy nutrition habits within the quarantine, alternative proposals of leisure entertainment like seminars, online theaters, online books, online tours, etc].

Implementing contingency and business continuity plans in order to safeguard production plants and enable the Group's supply chain to remain fully operational in order to ensure the uninterrupted business continuity and the continuous supply of high-demand products to the market.

As the needs of the consumers turned to specific product categories, the Group ensured its ability to respond to increased demand for specific product categories, such as home care and personal hygiene products as well as food supplements.

In addition, the Group entered into the production of antibacterial products, in the hand cleansing category, in order to meet the high demand for these products.

Maintenance of financial resilience and implementation of the Group's strategic plan in order to support the Group's further growth.

Amidst this extraordinary environment, and as the Group's priorities remained focused on the health & safety of its employees and the society and its uninterrupted business continuity, the Group managed to maintain a solid financial position and free cashflow generation, while executing its investment plan and creating further value to all stakeholders.

During the first half of 2021, investments realized relate to new product development, upgrading machinery equipment, expanding production capacity, while a dividend payment was done to the shareholders of the Company.

Given the continued uncertainty regarding the impact of the COVID-19, including macroeconomic and consumption impacts, as well as the uncertain evolution of the pandemic going forward across our geographical

region, financial results cannot be accurately predicted at the time.

However, the management is confident that the Group's agility and resilient business model, together with our people's capabilities, will help us navigate through this unprecedented period and allow us to continue following the Group's strategic expansion plan, stimulating further profitable growth. The Group's strong capital base, low net debt and strong cash flows, provide safety and the support necessary to mitigate any potential negative impact, enabling it to continue as a going concern.

4.7.7 Significant Accounting Policies

The significant accounting principles that were applied for the preparation of the interim condensed financial statements of the Group are in agreement with those that were adopted during the preparation of the annual financial statements of the Group for the year ended on 31st December 2019 except for the new standards and interpretations that were adopted whose application is mandatory for periods after 1st January 2021.

Furthermore, the financial statements include selected notes for the explanation of events and transactions, which are significant for the understanding of changes in the Group's and Company's financial position as compared to the latest available and published annual financial statements.

a. New Accounting Standards, amendments of standards and Interpretation that were applied in the financial statements

IFRS IASB Effective Date
IBOR reform and its effects on financial report – phase 2 1 January 2021

New and amended standards and Interpretations issued by the IASB that will apply for the first time in the next annual financial statements are not expected to impact the Group as they are either not relevant to the Group's activities or require accounting which is consistent with the Group's current accounting policies.

In addition to the above pronouncements, the IFRS Interpretations Committee has issued a number of agenda decisions which set out the Interpretations Committee's rationale on how the requirements of applicable IFRSs should be applied. Since 30 June 2020, agenda decisions have been finalised on the following topics:

Accounting Standard Topic
IAS 1 Presentation of Financial Statements Supply Chain Financing Arrangements – Reverse Factoring
IAS 38 Intangible Assets Configuration or Customisation Costs in a Cloud Computing
Arrangement
IFRS 9 Financial Instruments Hedging Variability in Cash Flows due to Real Interest Rates
IAS 19 Employee Benefits Attributing Benefit to Periods of Service
IAS 10 Events after the Reporting Period Preparation of Financial Statements when an Entity
is No Longer a Going Concern
IAS 2 Inventories Costs Necessary to Sell Inventories

IAS 19 Attributing Benefit to Periods of Service

The IFRS Interpretations Committee (IFRS IC) has issued, in May 2021, a tentative decision "Attributing Benefit to Periods of Service (IAS 19 Employee Benefits)" where additional explanatory application guidance is provided on the method used to attribute employee benefits on specific defined benefit schemes with similar characteristics of the scheme contemplated in article 8 of legislation Ν.3198/1955 which refers to staff retirement indemnity.

The application guidance modifies the method currently used in Greece to apply the basic principles of IAS 19 and as a result, entities which prepare IFRS financial statements are required to change their accounting policy accordingly. The tentative decision is effective immediately however, it was impracticable to be applied in the interim financial statements as at 30th June 2021.

Any changes will be presented as a change in accounting policy and applied retrospectively in the annual financial statements for the year ending 31 December 2021, adjusting comparatives balances for 2020 and the opening balance of reserves for amounts relating to previous periods, as if the new policy had always been applied.

The Company is currently investigating the impact of the change in the method to attribute the retirement benefits.

b.New standards, amendments to standards and interpretations issued not yet effective, nor early adopted

Mandatorily effective for
periods beginning on or after
IFRS 16 Leases: Covid-19-Related Rent Concessions beyond 30 June 2021 1 April 2021
Annual Improvements to IFRSs - 2018-2020 cycle 1 January 2022
IAS 16 Property, Plant and Equipment (Amendment – Proceeds before
Intended Use)
1 January 2022
IAS 37 Provisions, Contingent Liabilities and Contingent Assets
(Amendment – Onerous Contracts – Cost of Fulfilling a Contract)
1 January 2022
IFRS 3 Business Combinations (Amendment –
Reference to the
Conceptual Framework)
1 January 2022
IFRS 17 Insurance Contracts 1 January 2023
IAS 1 Presentation of Financial Statements and IAS 8 Accounting
Policies, Changes in Accounting Estimates and Errors (Amendment –
Classification of Liabilities as Current or Non-current)
1 January 2023
IAS 1 Presentation of Financial Statements and IFRS Practice Statement
2 (Amendment – Disclosure of Accounting Policies)
1 January 2023
IAS 8 Accounting policies, Changes in Accounting Estimates and Errors
(Amendment - Definition of Accounting Estimates)
1 January 2023
IAS 12 Income Taxes (Amendment - Deferred Tax related to Assets and
Liabilities arising from a Single Transaction)
1 January 2023

The Company and the Group are currently investigating the impact of the new standards and amendments on its financial statements.

4.8 FINANCIAL RISK MANAGEMENT

4.8.1 Capital Management

The Group's objectives as regards to management of capital, is to reassure the ability for the Group's smooth operation, aiming at providing satisfactory returns to shareholders and to maintain an ideal capital structure by reducing thus the cost of capital. The Group monitors its capital based on the leverage ratio. The leverage ratio is calculated by dividing net debt with total employed capital. Net debt is calculated as "Total debt" (including "short term and long-term debt" as presented in the Statement of Financial Position) minus "Cash and cash equivalents" and "financial assets at fair value through the profit and loss". The calculation of net debt does not include the

purchase of treasury shares. Total employed capital is calculated as "Shareholders' Equity" as presented in the statement of financial position plus net debt. The leverage ratio on 30 June 2021 was as follows:

Group
Amounts in € 30.06.2021 31.12.2020
Total Debt 64,780,363 56,413,014
Minus
Cash & cash equivalents (23,186,916) (40,595,341)
Financial assets at fair value through profit and loss (6,210,201) (4,909,195)
Net Debt 35,383,246 10,908,477
Shareholders' Equity 274,193,110 269,880,896
Total Employed Capital 309,576,356 280,789,373
Leverage Ratio 11.43% 3.88%

4.8.2 Financial Instruments

The Group's financial instruments mainly consist of bank deposits, bank overdrafts, trade debtors and creditors, investments in securities, other liabilities.

The financial assets and liabilities during the date of the financial statements can be classified as follows:

Group Company
Amounts in € 30.06.2021 31.12.2020 30.06.2021 31.12.2020
Non-current assets
Other long-term receivables 339,237 408,207 222,628 231,228
Total 339,237 408,207 222,628 231,228
Current assets
Trade receivables 99,879,902 90,951,747 51,393,588 45,583,265
Other receivables 7,652,298 6,921,480 6,614,773 3,628,334
Cash & cash equivalents 23,186,916 40,595,341 6,164,817 16,137,744
Financial assets at fair value through profit and loss 6,210,201 4,909,195 6,210,201 4,909,195
Total 136,929,316 143,377,763 70,383,379 70,258,538
Long-term Liabilities
Loans 48,413,329 48,607,624 38,496,250 44,000,000
Lease liabilities 8,601,116 10,595,268 3,190,104 3,974,856
Provisions and other long-term liabilities 2,905,520 2,836,813 0 7,087
Total 59,919,965 62,039,705 41,686,354 47,981,943
Short-term Liabilities
Loans 16,367,034 7,805,390 8,503,750 6,000,000
Lease liabilities 4,402,698 4,646,478 1,739,072 1,890,534
Suppliers 52,779,295 64,800,497 24,280,172 29,662,690
Other liabilities 12,962,757 9,220,899 9,914,646 6,048,675
Total 86,511,783 86,473,264 44,437,640 43,601,899

4.8.3 Definition of fair values

The following table presents the fixed assets measured at fair value, according to the measurement method. The different categories are as follows:

• Published market prices (without amendment or adjustment) for the financial assets traded in active money markets (level 1)

• Measurement or valuation techniques based directly on publicized market prices or calculated indirectly from publicized market prices for similar instruments (level 2).

• Measurement or valuation techniques that are not based on available information from current transactions in active money markets (level 3).

The financial assets measured at fair value during 30 June 2021 are as follows:

Group
Assets Level 1 Level 2 Level 3 Total
Tangible fixed assets 0 61,699,941 0 61,699,941
Investments in Property 0 1,021,382 0 1,021,382
Financial Assets at Fair Value through Profit and Loss 6,210,201 0 0 6,210,201
Company
Assets Level 1 Level 2 Level 3 Total
Tangible fixed assets 0 27,904,147 0 27,904,147
Investments in Property 0 31,857 0 31,857
Financial Assets at Fair Value through Profit and Loss 6,210,201 0 0 6,210,201

The fair value of own-use tangible fixed assets and investments in property is carried out by approved appraiser based on international rules and standards.

The fair value of financial assets traded on active markets (i.e. derivatives, equity, bonds, mutual funds), is defined based on the published prices in effect during the balance sheet date. A market is considered "Active" when there are available and revised prices in frequent intervals that are published by a stock exchange, broker, sector, rating agency or regulatory authority. Such financial instruments are included in level 1.

The fair value of financial assets not traded on active markets (i.e. over the counter derivative contracts) is defined using valuation techniques that are based primarily on available information for transactions carried out in active markets, while they use the least possible estimations by the entity. Such financial instruments are included in level 2.

If the valuation techniques are not based on available market information, then the financial instruments are included in level 3.

4.9 EXPLANATORY NOTES ON THE FINANCIAL STATEMENTS

4.9.1 Segment Reporting

For management purposes, the Group is organized in four basic business segments: Mass Market Cosmetics, Household Products, Other Sales and the Private Label Products. According to IFRS 8 – Operating Segments, the management monitors the operating results of the business segments separately with the objective to evaluate the performance and decision making as regards to the allocation of resources. The Group's results per segment are analyzed as follows:

Commercial Activity Sectors Personal Care Home Care Other Sales Private Label
(Polipak)
Income from
associate
companies
Group Total
Income from external customers 85,089,189 76,129,433 22,565,949 11,451,397 0 195,235,968
Earnings before interest & tax (EBIT) 5,850,397 9,563,632 2,036,916 1,102,191 6,348,113 24,901,249
Interest income 21,532 19,265 5,710 2,898 0 49,405
Interest expenses (260,275) (232,869) (69,026) (35,028) 0 (597,198)
Earnings before tax 5,767,577 9,489,532 2,014,951 1,091,045 6,348,113 24,711,218
Income tax 1,097,654 1,805,997 383,475 207,642 1,460,779 4,955,546
Earnings / losses after tax 4,669,922 7,683,535 1,631,477 883,403 4,887,334 19,755,671
Depreciation / amortization 2,718,211 2,431,987 720,879 547,333 0 6,418,410
Earnings before interest, tax,
depreciation & amortization (EBITDA)
8,568,608 11,995,619 2,757,795 1,649,524 6,348,113 31,319,659

For the period 01/01/2021 – 30/06/2021:

Commercial Activity Sectors Personal Care Home Care Other Sales Private Label
(Polipak)
Income from
associate
companies
Group Total
Income from external customers 78,769,632 71,669,648 22,377,990 10,871,718 0 183,688,988
Earnings before interest & tax (EBIT) 5,046,986 8,524,028 1,996,448 1,539,494 5,150,596 22,257,551
Interest income 14,891 13,549 4,230 2,055 0 34,726
Interest expenses (318,204) (289,522) (90,400) (43,918) 0 (742,045)
Earnings before tax 3,920,104 7,498,719 1,676,308 1,383,963 5,150,596 19,629,690
Income tax 694,533 1,328,563 296,995 245,199 1,074,288 3,639,578
Earnings / losses after tax 3,225,572 6,170,156 1,379,313 1,138,763 4,076,308 15,990,112
Depreciation / amortization 2,571,591 2,339,798 730,574 538,575 0 6,180,538
Earnings before interest, tax,
depreciation & amortization (EBITDA)
7,618,577 10,863,826 2,727,022 2,078,069 5,150,596 28,438,089

For the period 01/01/2020 –30/06/2020:

Notes:

  • Income from associate companies refers to income from the company Elsa Cosmetics Ltd and its subsidiaries.

  • The calculation of financial income & expenses and depreciation, amortization has been proportionate based on the sales of each business activity of the Group. The calculation of income tax is based proportionately on the earnings before tax of each of the Group's business activity.

The allocation of consolidated assets and liabilities to the Group's business segments is analyzed as follows:

Group Personal Care Home Care Other Sales Private Label (Polipak)
30.06.2021 31.12.2020 30.06.2021 31.12.2020 30.06.2021 31.12.2020 30.06.2021 31.12.2020 30.06.2021 31.12.2020
Total Assets 440,020,029 435,374,438 182,143,142 183,817,549 162,963,758 172,887,821 48,304,994 53,707,509 46,608,134 24,961,559
Total Liabilities 163,830,104 162,854,806 64,457,266 66,080,707 57,670,018 62,151,571 17,094,291 19,307,352 24,608,529 15,315,176

The Group's sales and non-current assets by geographical region are analyzed as follows:

Οι πωλήσεις του Ομίλου και τα μη κυκλοφοριακά στοιχεία ενεργητικού κατανέμονται ανά γεωγραφική περιοχή ως κάτωθι:

Revenue 01.01 -
30.06.2021
01.01 -
30.06.2020
Non Current Assets 30.06.2021 31.12.2020
Greece 69,245,900 67,635,771 Greece 77,825,717 77,284,733
Poland 46,809,068 42,452,175 Poland 46,505,869 34,391,475
Romania 27,555,817 24,215,643 Romania 7,754,974 8,132,130
Bulgaria 6,134,638 5,161,374 Bulgaria 919,639 1,086,424
Serbia 9,117,371 8,888,924 Serbia 890,989 1,048,399
Czech 11,027,632 9,558,093 Czech 15,941,330 15,838,665
Slovakia 2,951,179 2,936,760 Slovakia 326,324 339,012
Hungary 4,497,737 4,497,650 Hungary 2,050,421 2,137,242
North Macedonia 2,032,605 1,927,583 North Macedonia 447,057 514,753
Bosnia 1,568,128 1,318,080 Bosnia 221,374 256,061
Portugal 725,246 616,932 Portugal 2,111 4,355
Ukraine 12,603,024 13,342,220 Ukraine 16,857,290 16,627,371
Russia 967,623 1,137,781 Russia 93,440 90,787
Cyprus 0 0 Cyprus 25,254,899 25,649,283
France 0 0 France 597 585
Total 195,235,968 183,688,988 Total 195,092,031 183,401,276

4.9.2 Investments in associate companies

The consolidated financial statements of Sarantis Group incorporate the consolidated financial results of the company ELCA Cosmetics Ltd, based on the equity method.

The movement of the Group's participations in associate companies and joint ventures is analyzed as follows:

Amounts in €
Group 30.06.2021 31.12.2020
Opening Balance 25,649,283 21,458,228
Participation on associates gains 4,887,334 9,222,158
Dividends (5,253,323) (4,914,211)
Other total income (79,915)
Foreign exchange differences (28,395) (36,976)
Ending Balance 25,254,899 25,649,283

It is noted that the group and the company The Estée Lauder Companies Inc. ("EL") have agreed to amend the Shareholders Agreement governing ELCA, which was going to end in 2021, extending the term of the arrangement from June 30, 2021 to June 30, 2028.

Based on the new agreement, EL will have the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, until June 30, 2027.

4.9.3 Goodwill

The goodwill of the Group and the Company are analyzed as follows:

Amounts in Euros Group Company
Balance as at 1.1.2021 7,676,364 1,100,000
Acquisitions / Reductions
Impairments/Revaluation
Foreign exchange differences 24,897
Balance as at 30.06.2021 7,701,262 1,100,000
Amounts in Euros Group Company
Balance as at 1.1.2020 7,898,422 1,100,000
Acquisitions / Reductions
Impairments/Revaluation
Foreign exchange differences (222,058)
Balance as at 31.12.2020 7,676,364 1,100,000

4.9.4 Inventories

The inventories are analyzed as follows:

Group 30.06.2021 31.12.2020
Merchandise 78,859,044 79,753,887
Products 10,831,830 12,353,966
Raw Materials 15,874,134 17,839,677
Prepayments for stock purchase 3,110,561 860,997
Impairment due to obsolescence (676,888) (2,213,126)
Total 107,998,681 108,595,399
Company 30.06.2021 31.12.2020
Merchandise 27,326,616 26,961,135
Products 9,657,854 11,344,251
Raw Materials 8,834,646 12,157,803
Prepayments for stock purchase 1,043,029 437,133
Impairment due to obsolescence (191,162) (1,641,873)
Total 46,670,984 49,258,450

There is no pledge over the Group's and the Company's inventories.

The analysis of the provision for the impairment due to obsolescence is as follows:

Group 30.06.2021 31.12.2020
Opening Balance 2,213,126 2,274,919
Provision 1,268,182 1,800,893
Use of provision (2,818,596) (1,751,445)
Provision reserve (999) (38,886)
Foreign exchange differences 15,174 (72,354)
Closing balance 676,887 2,213,126
Company 30.06.2021 31.12.2020
Opening Balance 1,641,873 1,492,317
Provision 1,012,982 1,446,621
Use of provision (2,463,694) (1,297,064)
Provision reserve
Foreign exchange differences

No inventories were impaired due to reduced sales or operational suspension. It is noted that more than 90% of the Group's sales are generated from categories such as personal care & hygiene, home care and health & care, categories which are in high demand due to the needs arising from COVID-19.

4.9.5 Trade and other receivables

The trade receivables account is analyzed as follows:

Group 30.06.2021 31.12.2020
Trade receivables 79,106,643 83,238,504
Minus provisions (3,315,275) (3,550,375)
Net trade receivables 75,791,368 79,688,129
Checks and notes receivable 26,488,534 13,663,618
Minus provisions (2,400,000) (2,400,000)
Net checks and notes receivable 24,088,534 11,263,618
Total 99,879,902 90,951,747
Company 30.06.2021 31.12.2020
Trade receivables 30,004,657 36,932,468
Minus provisions (1,877,090) (1,855,636)
Net trade receivables 28,127,567 35,076,832
Checks and notes receivable 25,666,021 12,906,433
Minus provisions (2,400,000) (2,400,000)
Net checks and notes receivable 23,266,021 10,506,433
Total 51,393,588 45,583,265

As the Group's core sales network focuses on the mass market retail channel, which has remained fully operational due to increased consumer needs, there is a normal flow of receivables from customers.

The other receivables are analyzed as follows:

Group 30.06.2021 31.12.2020
Accounts receivable in legal contest 425,132 425,134
Sundry Debtors 5,018,425 3,146,064
Short-term Lease Receivables 91,503 216,755
Prepayments and accrued income 2,480,117 3,397,279
Accounts for management of prepayments & credits 47,382 46,511
Minus provisions (410,261) (310,264)
Total 7,652,298 6,921,480
Company 30.06.2021 31.12.2020
Accounts receivable in legal contest 425,136 425,136
Sundry Debtors 1,611,953 713,750
Receivables from dividends 3,067,848 1,728,348
Short-term Lease Receivables 91,503 181,871
Prepayments and accrued income 1,781,215 842,983
Accounts for management of prepayments & credits 47,382 46,511
Minus provisions (410,266) (310,266)
Total 6,614,773 3,628,334

The analysis of the provision for trade receivables and for other receivables is as follows:

Group 30.06.2021 31.12.2020
Opening balance 6,260,639 6,446,024
Additions 119,484 207,822
Receivables written off -334,120 -19,434
Amounts offset 10,011 -83,461
Foreign exchange differences 69,523 -290,311
Υπόλοιπο λήξης 6,125,537 6,260,639
Company 30.06.2021 31.12.2020
Opening balance 4,565,901 4,506,280
Additions 100,000 67,045
Receivables written off 0 0
Amounts offset 21,454 -7,423
Υπόλοιπο λήξης 4,687,355 4,565,901

4.9.6 Cash & cash equivalents

Cash & cash equivalents represent cash in hand of the Group and company and bank deposits available at first demand, which are analyzed as follows:

Group 30.06.2021 31.12.2020
Cash in hand 126,623 342,844
Bank deposits 23,060,293 40,252,497
Total 23,186,916 40,595,341
Company 30.06.2021 31.12.2020
Cash in hand 102,508 322,674
Bank deposits 6,062,309 15,815,070

4.9.7 Financial Assets at Fair Value through Results

Group Company
30.06.2021
31.12.2020
30.06.2021 31.12.2020
Opening Balance 4,909,195 2,514,360 4,909,195 2,514,360
Acquisitions 3,952,342 9,041,818 3,952,342 9,041,818
Cost of disposals (3,069,816) (6,457,126) (3,069,816) (6,457,126)
Fair value adjustments 418,479 (189,857) 418,479 (189,857)
Foreign exchange differences
Closing balance 6,210,201 4,909,195 6,210,201 4,909,195

The above items are placements with a short-term investment horizon that are traded on active markets.

4.9.8 Trade and other liabilities

The Company's and Group's trade and other liabilities are analyzed as follows:

Group 30.06.2021 31.12.2020
Suppliers 50,267,167 60,921,970
Checks payable 2,512,128 3,878,527
Total 52,779,295 64,800,497
Company 30.06.2021 31.12.2020
Suppliers 21,768,044 25,784,163
Checks payable 2,512,128 3,878,527

The other liabilities of the Company and the Group are analyzed as follows:

Group 30.06.2021 31.12.2020
Social Security Funds 1,279,336 1,780,949
Customer Prepayments 1,002,683 1,668,507
Long-term Liabilities payable in the following year 0 24,464
Government Grants 1,095,715 1,215,936
Dividends Payable 32,224 33,104
Accruals and deferred expenses 5,930,907 3,131,359
Sundry Creditors 3,621,891 1,366,579
Total 12,962,757 9,220,899
Company 30.06.2021 31.12.2020
Social Security Funds 645,886 1,167,084
Customer Prepayments 3,860,143 2,487,567
Short-term Liabilities towards Related Companies 548,255 558,255
Government Grants 14,697 8,885
Dividends Payable 32,224 33,104
Accruals and deferred expenses 1,905,153 967,491
Sundry Creditors 2,908,287 826,290

The Group does not depend on suppliers who have suspended their operations or who are expected to be significantly affected by COVID-19.

4.9.9 Provisions and other long-term liabilities

The provisions and other long-term liabilities are analyzed as follows:

Group 30.06.2021 31.12.2020
Government Grants 2,215,314 2,177,277
Other provisions 548,972 492,429
Other long-term liabilities 141,234 167,107
Total 2,905,520 2,836,813
Company 30.06.2021 31.12.2020
Government Grants 0 7,087
Total 0 7,087

4.9.10 Loans

Loans are analyzed as follows:

Group Company
Short-term loans 30.06.2021 31.12.2020 30.06.2021 31.12.2020
Bank loans 15,323,284 7,805,390 1,460,000 0
Bond Loans 1,043,750 0 7,043,750 6,000,000
Long-term loans
Bank loans 39,457,079 28,607,624 8,540,000 0
Bond Loans 8,956,250 20,000,000 29,956,250 44,000,000
Total 64,780,363 56,413,014 47,000,000 50,000,000

The Group's bank loans concern loans for working capital and Bond Loans.

During the first half of 2021, the remaining 10 mil. Euros amount from the initial 20mil. Euro loan which was granted by Eurobank S.A. to GR. SARANTIS S.A, was fully repaid.

Moreover, during the 1st half year of 2021 a loan amounting to 10mil. Euros was granted to GR SARANTIS S.A by EBRD.

Furthermore, an investment loan amounting to 6.6mil. Euros was granted by BNP PARIBAS to POLIPAK.

4.9.11 Income tax

Group Company
01.01-30.06.2021 01.01-30.06.2020 01.01-30.06.2021 01.01-30.06.2020
Income tax (5,551,973) (5,165,571) (807,370) (947,812)
Deferred tax 596,426 1,525,993 (402,286) 368,823
Total (4,955,546) (3,639,578) (1,209,656) (578,989)

With regard to the fiscal year 2020, the Company is subject to the tax audit of the Certified Auditors stipulated by the provisions of article 65A of Law 4174/2013. The audit is under progress and the relevant tax certificate is expected to be granted after the release of the semi-annual financial statements for the period 01.01-30.06.2021. The Management of the Company does not expect the emergence of any significant tax obligations apart from those already depicted in the financial statements.

Additionally, the Company's tax rate, according to no. 58 L.4172 / 2013, as amended by article 120 of law 4799/2021 (Government Gazette A '78 / 18-05-2021) and is in force, amounts to 22%.

4.9.12 Financial Income / Expenses

The financial income / expenses are analyzed as follows:

Group 01.01 - 30.06.2021 01.01 - 30.06.2020
Interest Expense (597,198) (742,045)
Interest Income 49,405 34,726
Foreign exchange differences (148,486) (1,174,488)
Gain from sale of participations & securities 366,487 147,177
Loss from sale of participations & securities (22,636) (105,371)
Other financial income/expense 162,397 (800,220)
Total (190,031) (2,640,221)
Company 01.01 - 30.06.2021 01.01 - 30.06.2020
Interest Expense (558,834) (632,038)
Interest Income 15,292 59,545
Foreign exchange differences (15,127) 37,912
Gain from sale of participations & securities 366,487 147,177
Loss from sale of participations & securities (22,636) (105,371)
Dividends from subsidiaries 16,278,150 7,216,165
Other financial income/expense 379,506 (608,146)
Total 16,442,837 6,115,244

4.9.13 Share Capital

Share Capital
Number of shares Share premium Total
30.06.2021 69,877,484 0.78 54,504,438 40,676,356 95,180,793
31.12.2020 69,877,484 0.78 54,504,438 40,676,356 95,180,793
31.12.2019 69,877,484 0.78 54,504,438 40,676,356 95,180,793

4.9.14 Earnings per Share

Earnings per share were calculated according to the weighted average number of shares after the deduction of the weighted average number of treasury shares held by the Company.

Group Company
01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020
Earnings after tax attributed to the owners of the Company 19,506,183 15,617,534 20,078,616 9,322,212
Weighted average number of shares 67,006,739 67,145,884 67,006,739 67,145,884
Earnings per share (€ ) 0.2912 0.2326 0.2997 0.1388

4.9.15 Dividends

❖ For the period ended on 30/06/2021:

The Ordinary General Meeting of shareholders during its meeting on 20.05.2021 approved the distribution of a dividend of 0.214661421 Euros per share or a total amount of 15mil. Euros. According to the legislation in effect, the dividend that corresponded to 2,891,424 treasury shares of the Company increased the total dividend granted to other shareholders and therefore the total gross dividend per share accounted for 0.22392718 Euros.

❖ For the period ended on 30/06/2020:

The Ordinary General Meeting of shareholders during its meeting on 07.05.2020 approved the distribution of a dividend of 0.1604814 Euros per share or a total amount of 11,214,034 Euros. According to the legislation in effect, the dividend that corresponded to 2,731,600 treasury shares of the Company increased the total dividend granted to other shareholders and therefore the total gross dividend per share accounted for 0.16701 Euros.

4.9.16 Treasury Shares

During the first half of 2021, the Company proceeded to the purchase of 67,429 treasury shares at an average purchase price of 8.96 euro per share, paying 604,210 euro.

Including the 2,825,995 treasury shares already held by the company as of 31/12/2021, the Company holds in total 2,893,424 treasury shares with nominal value of EUR 0.78 per share and an average purchase price of 4.82 euro per share, having paid a total of 13,934,604 euro.

The treasury shares that the Company holds correspond to 4.14% of its share capital.

4.9.17 Table of changes in fixed assets

4.9.17.1 Company

Land - fields Buildings, building
facilities and technical
projects
Investment property Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Acquisition cost 1.1.2020 8,550,833 35,712,545 31,972 16,794,644 1,048,714 12,286,365 134,992 29,129,726 103,689,791
Acquisitions 0 566,961 0 1,068,506 23,513 761,090 1,617,004 11,231,695 15,268,768
Reclassifications 0 36,733 0 (4,564) 0 4,746 (111,610) 74,696 0
Revaluation (245,218) 684,942 0 0 0 0 0 0 439,724
Write-offs 0 (326,932) 0 0 0 (889,161) (18,510) 0 (1,234,603)
Cost of disposals 0 0 0 0 (31,620) (6,319) 0 0 (37,939)
Value as at 31.12.2020 8,305,615 36,674,248 31,972 17,858,586 1,040,607 12,156,721 1,621,876 40,436,117 118,125,742

Land - fields Buildings, building
facilities and technical
projects
Investment property Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Depreciations 1.1.2020 0 16,978,390 115 9,790,071 812,248 8,583,725 0 7,469,897 43,634,448
Depreciations for the Period 0 1,250,487 0 1,111,406 52,646 1,124,072 0 1,530,172 5,068,783
Revaluation 0 404,562 0 0 0 0 0 0 404,562
Depreciation on write-offs 0 (326,837) 0 0 0 (876,687) 0 0 (1,203,524)
Depreciation of disposals 0 0 0 0 (31,620) (6,148) 0 0 (37,768)
Depreciations 31.12.2020 0 18,306,603 115 10,901,477 833,274 8,824,961 0 9,000,069 47,866,501
Net book value as at 31.12.2020 8,305,615 18,367,645 31,857 6,957,109 207,333 3,331,759 1,621,876 31,436,048 70,259,241
Land - fields Buildings, building
facilities and technical
projects
Investment property Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Acquisition cost 1.1.2021 8,305,615 36,674,248 31,972 17,858,586 1,040,607 12,156,721 1,621,876 40,436,117 118,125,742
Acquisitions 0 48,753 0 1,427,988 28,469 422,964 1,993,491 28,243 3,949,908
Reclassifications 0 8,267 0 1,698,909 0 9,973 (1,798,476) 81,327 0
Write-offs 0 0 0 0 0 (593,022) 0 0 (593,022)
Cost of disposals 0 0 0 0 (30,000) (1,568) 0 0 (31,568)
Value as at 30.6.2021 8,305,615 36,731,268 31,972 20,985,483 1,039,076 11,995,068 1,816,891 40,545,687 121,451,061

SEMI-ANNUAL FINANCIAL REPORT FOR THE PERIOD: 1/1/2021 – 30/06/2021

Land - fields Buildings, building
facilities and technical
projects
Investment property Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Depreciations 1.1.2021 0 18,306,603 115 10,901,477 833,274 8,824,961 0 9,000,069 47,866,501
Depreciations for the Period 0 643,024 0 600,993 25,389 473,728 0 786,730 2,529,865
Depreciation on write-offs 0 0 0 0 0 (589,855) 0 0 (589,855)
Depreciation of disposals 0 0 0 0 (7,150) (1,092) 0 0 (8,242)
Depreciations 30.6.2021 0 18,949,627 115 11,502,470 851,513 8,707,743 0 9,786,800 49,798,269
Net book value as at 30.6.2021 8,305,615 17,781,641 31,857 9,483,013 187,563 3,287,325 1,816,891 30,758,887 71,652,792

The right of use assets for the Company as at 30 th June 2021 are as follows:

Buildings, building
facilities and
technical projects
Vehicles Total
Acquisition cost 1.1.2020 3,764,903 2,337,923 6,102,826
Acquisitions 2,745,829 133,924 2,879,753
Write-offs (352,608) (77,188) (429,796)
Value as at 31.12.2020 6,158,123 2,394,659 8,552,782
Buildings, building
facilities and
technical projects
Vehicles Total
Depreciations 1.1.2020 907,065 592,230 1,499,295
Depreciations for the Period 1,084,175 660,011 1,744,186
Depreciation on write-offs (328,494) (56,469) (384,963)
Depreciations 31.12.2020 1,662,745 1,195,773 2,858,518
Net book value as at 31.12.2020 4,495,378 1,198,886 5,694,264
Buildings, building
facilities and
technical projects
Vehicles Total
Acquisition cost 1.1.2021 6,158,123 2,394,659 8,552,782
Acquisitions 3,022 59,827 62,848
Write-offs (159,893) (55,232) (215,125)
Value as at 30.6.2021 6,001,252 2,399,253 8,400,505
Buildings, building
facilities and
technical projects
Vehicles Total
Depreciations 1.1.2021 1,662,745 1,195,773 2,858,518
Depreciations for the Period 550,091 334,168 884,259
Depreciation on write-offs (159,893) (32,675) (192,568)
Depreciations 30.6.2021 2,052,942 1,497,266 3,550,208
Net book value as at 30.6.2021 3,948,310 901,988 4,850,297

4.9.17.2 Group

Land - fields Buildings, building
facilities and
technical projects
Investment
property
Machinery,
technical
installations and
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Acquisition cost 1.1.2020 11,116,955 49,249,832 1,032,727 41,314,472 2,693,227 13,532,516 1,708,456 64,741,919 185,390,104
Acquisitions 17,531 635,294 0 1,891,008 124,102 903,794 12,366,606 11,765,973 27,704,309
Reclassifications 0 36,568 0 1,340,369 36,976 (180,864) (1,307,744) 74,696 0
Revaluation (234,245) 1,355,177 19,057 0 0 0 0 0 1,139,988
Write-offs 0 (326,932) 0 (111,828) (53,220) (889,401) (127,481) (13,809) (1,522,672)
Cost of disposals 0 0 0 (906,835) (139,801) (57,415) 0 (123) (1,104,174)
Foreign exchange differences (216,566) (1,893,541) (18,643) (3,102,743) (118,709) (96,605) (597,800) (1,014,818) (7,059,424)
Value as at 31.12.2020 10,683,675 49,056,398 1,033,141 40,424,444 2,542,574 13,212,025 12,042,037 75,553,838 204,548,131
Land - fields Buildings, building
facilities and
technical projects
Investment
property
Machinery,
technical
installations and
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Depreciations 1.1.2020 0
20,440,850
115 20,755,885 1,905,221 9,297,502 0 13,052,237 65,451,811
Depreciations for the Period 0
1,560,074
0 2,925,252 196,628 1,213,043 0 2,381,423 8,276,420
Revaluation 0
610,196
0 0 0 0 0 0 610,196
Depreciations of reclassifications 0
(4,462)
0 126,253 33,698 (155,488) 0 0 0
Depreciation on write-offs 0
(326,837)
0 (96,824) (39,386) (876,873) 0 (13,809) (1,353,728)
Depreciation of disposals 0
0
0 (632,837) (126,806) (38,590) 0 (123) (798,356)
Foreign exchange differences 0
(620,554)
0 (1,385,107) (81,633) (61,066) 0 (247,211) (2,395,571)
Depreciations 31.12.2020 0
21,659,267
115 21,692,623 1,887,722 9,378,528 0 15,172,516 69,790,772
Net book value as at 31.12.2020 10,683,675 27,397,130 1,033,026 18,731,821 654,852 3,833,496 12,042,037 60,381,322 134,757,359
Land - fields Buildings, building
facilities and
technical projects
Investment
property
Machinery,
technical
installations and
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Acquisition cost 1.1.2021 10,683,675 49,056,398 1,033,141 40,424,444 2,542,574 13,212,025 12,042,037 75,553,838 204,548,131
Acquisitions 7,197 48,753 0 1,756,445 65,069 445,723 13,683,484 46,281 16,052,951
Reclassifications 0 301,437 0 1,764,255 71,503 10,591 (2,229,113) 81,327 0
Write-offs 0 0 0 (19,361) (37,217) (595,870) (81,416) (53,169) (787,033)
Cost of disposals 0 0 0 (12,885) (50,003) (4,680) 0 0 (67,567)
Foreign exchange differences 53,989 481,524 (11,644) 786,473 31,509 15,294 272,994 468,211 2,098,351
Value as at 30.6.2021 10,744,860 49,888,111 1,021,497 44,699,371 2,623,436 13,083,083 23,687,987 76,096,488 221,844,832
Land - fields Buildings, building
facilities and
technical projects
Investment
property
Machinery,
technical
installations and
Vehicles Furniture and other
equipment
Fixed assets under
construction and
prepayments
Intangible assets Total
Depreciations 1.1.2021 0
21,659,267
115 21,692,623 1,887,722 9,378,528 0 15,172,516 69,790,772
Depreciations for the Period 0
803,158
0 1,505,201 92,717 518,436 0 1,219,467 4,138,979
Depreciation on write-offs 0
0
0 (15,769) (26,602) (592,703) 0 (53,169) (688,242)
Depreciation of disposals 0
0
0 (8,727) (27,153) (3,210) 0 0 (39,089)
Foreign exchange differences 0
158,592
0 376,412 21,068 8,780 0 74,258 639,111
Depreciations 30.6.2021 0
22,621,017
115 23,549,740 1,947,753 9,309,831 0 16,413,073 73,841,530
Net book value as at 30.6.2021 10,744,860 27,267,094 1,021,382 21,149,630 675,683 3,773,251 23,687,987 59,683,415 148,003,302

The increase in "Fixed Assets under construction and prepayments" during the first half of 2021 is mainly due to the project in progress at Polipak, which is expected to be complete within 2022.

The net book value of the Group's intangible assets as at 30/06/2021 consists of trademarks - rights amounting to approximately 53.3 million euros (53.9 million euros on 31/12/2020) and software programs amounting to approximately 6.3 million euros (6.5 million euroson 31/12/2020).

Respectively, the net book value of the Company's intangible assets as at 30/06/2021 consists of trademarks - rights amounting to approximately 27.2 million euros (27.7 million euros on 31/12/2020) and software programs amounting to approximately EUR 3.6 million (EUR 3.7 million on 31/12/2020).

The right of use assets for the Group as at 30 th June 2021 are as follows:

Land - fields Buildings, building
facilities and
technical projects
Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Total
Acquisition cost 1.1.2020 295,575 11,037,268 21,685 4,163,235 94,034 15,611,797
Acquisitions 0 4,768,275 0 2,817,440 0 7,585,715
Write-offs (1,063) (421,778) (20,776) (636,979) 0 (1,080,597)
Foreign exchange differences (70,648) (413,052) (909) (77,130) (1,740) (563,479)
Value as at 31.12.2020 223,864 14,970,713 0 6,266,566 92,294 21,553,436
Land - fields Buildings, building
facilities and
technical projects
Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Total
Depreciations 1.1.2020 10,714 2,398,205 8,674 1,221,642 12,393 3,651,628
Depreciations for the Period 9,142 2,780,764 5,540 1,559,951 13,298 4,368,696
Depreciation on write-offs 0 (360,140) (13,851) (579,337) 0 (953,328)
Foreign exchange differences (3,602) (116,142) (364) (15,822) (317) (136,246)
Depreciations 31.12.2020 16,255 4,702,688 0 2,186,434 25,375 6,930,751
Net book value as at 31.12.2020 207,609 10,268,025 0 4,080,132 66,919 14,622,686
Land - fields Buildings, building
facilities and
technical projects
Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Total
Acquisition cost 1.1.2021 223,864 14,970,713 0 6,266,566 92,294 21,553,436
Acquisitions 0 64,492 0 215,641 0 280,133
Write-offs 0 (282,913) 0 (141,162) 0 (424,075)
Foreign exchange differences 16,895 90,340 0 30,330 (1,073) 136,491
Value as at 30.6.2021 240,759 14,842,632 0 6,371,375 91,220 21,545,986
Land - fields Buildings, building
facilities and
technical projects
Machinery, technical
installations and
other equipment
Vehicles Furniture and other
equipment
Total
Depreciations 1.1.2021 16,255 4,702,688 0 2,186,434 25,375 6,930,751
Depreciations for the Period 4,199 1,422,541 0 861,024 6,491 2,294,255
Depreciation on write-offs 0 (207,939) 0 (92,357) 0 (300,296)
Foreign exchange differences 1,382 37,273 0 7,133 (329) 45,458
Depreciations 30.6.2021 21,836 5,954,562 0 2,962,233 31,537 8,970,167
Net book value as at 30.6.2021 218,923 8,888,070 0 3,409,141 59,684 12,575,819

4.9.18 Number of Employees

Group Company
01.01 - 30.06.2021 01.01 - 30.06.2020 01.01 - 30.06.2021 01.01 - 30.06.2020
Regular employees 2,186 2,215 770 789
Day-wage employees 352 557 9
0
9
5
Total Employees 2,538 2,772 860 884

The number of employees for the Group and Company is as follows:

4.9.19 Litigation Cases

There are no pending or under arbitration legal cases and decisions by judicial or arbitration bodies which may significantly affect the financial statements of the Group and the Company, apart from the case of Marinopoulos S.A., where the Company has a claim of 2.4 million euros, that is included in the Company's provisions.

4.9.20 Contingent Liabilities

During the period 01.01 – 30.06.2021 there are no contingent liabilities either in the Group or the Company.

4.9.21 Contractual Obligations

Α. Guarantees

The Company has guaranteed loan liabilities of its subsidiaries.

B. Capital investment commitments

A new investment in the subsidiary company Polipak is in progress that will lead to a more automated production process. The cost of this project for the following years and until it is completed is estimated at approximately € 25 million.

4.9.22 Events after the Balance Sheet Date

The Group announced on July 8th 2021 that, in accordance with the terms and conditions of the amended Shareholders Agreement entered into with Estee Lauder Europe, Inc. ("EL Europe") with respect to the company ELCA Cosmetics Limited ("ELCA"), EL Europe provided the first call option notice for the purchase of shares held by the Group. The first call option represents 9% of ELCA's shares.

ELCA is a joint venture that was created in 2001 for the sale and distribution of beauty products in Greece, Romania, Bulgaria and Cyprus. ELCA is currently owned by Sarantis Group, which holds a 49% interest in the joint venture and EL Europe which holds the remaining 51% interest.

ELCA is based in Cyprus and fully owns the subsidiary companies ESTEE LAUDER HELLAS S.A. Cosmetics Distribution, ΕSTEE LAUDER BULGARIA EOOD and ESTEE LAUDER ROMANIA Srl., based in Greece, Bulgaria and Romania respectively.

Based on the amended Shareholders Agreement, EL Europe has the right to increase its interest in ELCA to 100% by purchasing shares held by the Group, including the right to increase its stake based on the financial statements of ELCA at June 30th 2021, June 30th 2024 and June 30th 2027 for 9%, 25% and 15% respectively.

The Group's strategy with respect to ELCA remains unchanged and is based on two factors:

1) utilizing the liquidity that will be created during the period 2021-2027 behind acquisitions that satisfy the Group's criteria and are able to provide synergies and contribute to profitability; 2) absorbing new distribution agreements that will further strengthen the Group's product portfolio.

As always, the management's goal is to execute its investment plan, focusing on its strategic product categories, geographical expansion and cost efficiencies, ultimately creating further value to its shareholders.

❖ During July 16th 2021, the Extraordinary General Shareholders' Meeting of "GR. SARANTIS S.A." took place, with the sole item on the agenda being the approval of the Suitability Policy for the BoD members according to article 3. paragraph 3 of the law 4706/2020.

Read the resolutions of the Extraordinary General Shareholders Meeting of July 16th 2021.

4.9.23 Related party transactions

The most significant transactions between the Company and its related parties, as such are defined by International Accounting Standard 24, are presented below.

Company
Subsidiaries
Trade receivables 30.06.2021 31.12.2020
Sarantis Belgrade D.O.O 39,750 88,281
Sarantis Banja Luca DOO 0 197
Sarantis Skopje D.O.O 0 245
Sarantis Bulgaria LTD 157,023 153,617
Sarantis Romania S.A. 799,271 582,200
Sarantis Polska S.A. 884,047 723,296
Sarantis Czech Republic sro 1,297,134 1,422,939
Polipak SP.Z.O.O. 6,414 47,530
Sarantis Slovakia S.R.O 156,089 320,150
Ergopack LLC 1,092,792 1,108,875
Sarantis Hungary Kft. 113,218 303,954
Sarantis Portugal Lda 595,831 1,119,722
Elode France SARL 28,480 27,734
Total 5,170,050 5,898,740
Trade Liabilities 30.06.2021 31.12.2020
Sarantis Belgrade D.O.O 2,020,204 1,067,589
Sarantis Banja Luca DOO 4,251 5,648
Sarantis Skopje D.O.O 1,033,479 301,140
Sarantis Bulgaria LTD 17,108 0
Sarantis Romania S.A. 80,748 10,687
Sarantis Polska S.A. 425,791 629,875
Sarantis Czech Republic sro 18,525 0
Polipak SP.Z.O.O. 753,921 321,052
Sarantis Slovakia S.R.O 4,252 0
Ergopack LLC 61,699 470
Sarantis Hungary Kft. 11,532 10,626
Sarantis Portugal Lda 744 0
Sarantis France SARL 48,200 48,960
Total 4,480,454 2,396,047
Liabilities from loans 30.06.2021 31.12.2020
Liabilities from loans 30.06.2021 31.12.2020
Sarantis Bulgaria LTD 6,751,855 7,501,237
Sarantis Romania S.A. 13,503,711 15,002,474
Sarantis Polska S.A. 6,751,855 7,501,237
Waldeck LTD 559,194 558,255
Total 27,566,616 30,563,203
Grand Total Liabilities 32,047,069 32,959,250

Income

Income from sale of merchandise 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 1,004,745 1,353,981
Sarantis Skopje D.O.O 267,476 358,324
Sarantis Bulgaria LTD 845,471 968,681
Sarantis Romania S.A. 2,883,377 3,645,733
Sarantis Polska S.A. 3,927,582 3,904,976
Sarantis Czech Republic sro 2,279,745 1,658,030
Sarantis Slovakia S.R.O 929,323 428,420
Ergopack LLC 529,042 662,119
Sarantis Hungary Kft. 244,492 331,088
Sarantis Portugal Lda 355,733 387,868
Total 13,266,985 13,699,221
Income – Interest 01.01 - 30.06.2021 01.01 - 30.06.2020
Ergopack LLC 0 53,849
Total 0 53,849
Other Income 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 88,953 99,059
Sarantis Banja Luca DOO 4,251 2,249
Sarantis Skopje D.O.O 10,772 9,018
Sarantis Bulgaria LTD 17,481 11,727
Sarantis Romania S.A. 41,791 41,038
Sarantis Polska S.A. 264,445 122,452
Sarantis Czech Republic sro 74,123 38,905
Polipak SP.Z.O.O. 30,716 14,345
Sarantis Slovakia S.R.O 31,406 13,938
Ergopack LLC 78,581 120,705
Sarantis Hungary Kft. 31,727 39,188
Sarantis Portugal Lda 27,081 32,609
Total 701,328 545,234
Grand Total Income 13,968,314 14,298,303

Expenses and Purchases

Purchases of Merchandise - Services 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Belgrade D.O.O 0 6,938
Sarantis Romania S.A. 49,732 7,355
Sarantis Polska S.A. 868,115 877,614
Sarantis Czech Republic sro 399 6,829
Polipak SP.Z.O.O. 1,491,492 2,056,495
Sarantis Slovakia S.R.O 1,424 0
Ergopack LLC 0 2,736
Total 2,411,162 2,957,967
Expenses – Interest 01.01 - 30.06.2021 01.01 - 30.06.2020
Sarantis Bulgaria LTD 70,626 93,844
Sarantis Romania S.A. 141,251 188,006
Sarantis Polska S.A. 70,626 94,279
Waldeck LTD 10,939 11,000
Total 293,441 387,128
Grand Total Expenses 2,704,603 3,345,094
Table of Disclosures of Related Parties
Group
Company
a) Income 0 13,968,314
b) Expenses 0 2,704,603
c) Receivables 0 5,170,050
d) Liabilities 0 32,047,069
e) Transactions and remuneration of senior executives and management 1,686,693 1,686,693
f) Receivables from senior executives and management 84,778 84,778
g) Liabilities towards senior executives and management 0 0
h) Receivables from affiliates 178 178
i) Liabilities to affiliates 0 0

It is noted that related party transactions are done at market purchase prices.

4.9.24 Business Units and Geographical Analysis Tables

4.9.24.1 Breakdown by Business Unit

SBU Turnover (€ mil) H1 '21 % H1 '20
Personal Care 85.09 8.02% 78.77
% of Total 43.58% 42.88%
Own 55.80 12.22% 49.72
% of SBU 65.58% 63.12%
Distributed 29.29 0.83% 29.05
% of SBU 34.42% 36.88%
Home Care 76.13 6.22% 71.67
% of Total 38.99% 39.02%
Own 74.92 5.29% 71.15
% of SBU 98.41% 99.28%
Distributed 1.21 134.54% 0.52
% of SBU 1.59% 0.72%
Private Label 11.45 5.33% 10.87
% of Total 5.87% 5.92%
Other Sales 22.57 0.84% 22.38
% of Total 11.56% 12.18%
Health Care 4.31 -8.33% 4.70
% of SBU 19.11% 21.02%
Luxury Cosmetics 18.25 3.28% 17.67
% of SBU 80.89% 78.98%
Total Turnover 195.24 6.29% 183.69
SBU EBIT (€ mil) H1 '21 % H1 '20
Personal Care 5.85 15.92% 5.05
Margin 6.88% 6.41%
% of EBIT 23.49% 22.68%
Own 5.52 22.84% 4.50
Margin 9.90% 9.04%
% of EBIT 22.18% 20.20%
Distributed 0.33 -40.59% 0.55
Margin 1.12% 1.90%
% of EBIT 1.31% 2.48%
Home Care 9.56 12.20% 8.52
Margin 12.56% 11.89%
% of EBIT 38.41% 38.30%
Own 9.46 11.50% 8.48
Margin 12.63% 11.92%
% of EBIT 37.99% 38.12%
Distributed 0.10 160.01% 0.04
Margin 8.54% 7.70%
% of EBIT 0.42% 0.18%
Private Label 1.10 -28.41% 1.54
Margin 9.62% 14.16%
% of EBIT 4.43% 6.92%
Other Sales 2.04 2.03% 2.00
Margin 9.03% 8.92%
% of EBIT 8.18% 8.97%
Health Care 0.52 -31.59% 0.76
Margin 12.09% 16.20%
% of EBIT 2.09% 3.42%
Luxury Cosmetics 1.52 22.78% 1.23
Margin 8.30% 6.98%
% of EBIT 6.09% 5.55%
Income from Associated Companies 6.35 23.25% 5.15
% of EBIT 25.49% 23.14%
Total EBIT 24.90 11.88% 22.26
Margin 12.75% 12.12%

4.9.24.2 Geographical Breakdown

Country Turnover (€ mil) H1 '21 % H1 '20
Greece 69.25 2.38% 67.64
% of Total Turnover 35.47% 36.82%
Poland 35.36 11.96% 31.58
Poland - Polipak 11.45 5.33% 10.87
Romania 27.56 13.79% 24.22
Bulgaria 6.13 18.86% 5.16
Serbia 9.12 2.57% 8.89
Czech Republic 11.03 15.37% 9.56
Slovakia 2.95 0.49% 2.94
Hungary 4.50 0.00% 4.50
North Macedonia 2.03 5.45% 1.93
Bosnia 1.57 18.97% 1.32
Portugal 0.73 17.56% 0.62
Ukraine 12.60 -5.54% 13.34
Russia 0.97 -14.96% 1.14
Foreign Countries Subtotal 125.99 8.56% 116.05
% of Total Turnover 64.53% 63.18%
Total Turnover 195.24 6.29% 183.69
Country ΕΒΙΤ (€ mil) H1 '21 % H1 '20
Greece 15.49 19.27% 12.99
% of Total Ebit 62.20% 58.34%
Poland 3.43 0.24% 3.43
Poland-Polipak 1.10 -28.41% 1.54
Romania 2.82 27.00% 2.22
Bulgaria 0.19 -44.84% 0.35
Serbia 0.37 -32.45% 0.55
Czech Republic 1.17 82.35% 0.64
Slovakia 0.24 6884.70% 0.00
Hungary 0.05 529.66% 0.01
North Macedonia 0.21 -9.14% 0.23
Bosnia -0.11 -102.41% -0.05
Portugal -0.07 48.47% -0.13
Ukraine 0.02 -96.55% 0.46
Russia -0.01 157.14% 0.02
Foreign Countries Subtotal 9.41 1.52% 9.27
% of Total Ebit 37.80% 41.66%
Total EBIT 24.90 11.88% 22.26

Marousi, September 8th 2021

THE CHAIRMAN OF
THE BOARD
MANAGING
DIRECTOR
THE GROUP'S CHIEF
FINANCIAL OFFICER &
BOARD MEMBER
THE COMPANY'S
FINANCE DIRECTOR
THE ACCOUNTANT
DIRECTOR
GRIGORIS SARANTIS KYRIAKOS SARANTIS KONSTANTINOS ROZAKEAS ANASTASIA
STAVROULA LATSOU
EFSTATHIOS STEFAS
ID No. Χ 080619/03 ID No. ΑΙ
597050/2010
ID No. ΑΚ 783631/13 ID No. ΑΑ 128208/05 ID No. ΑI 988547/12

Talk to a Data Expert

Have a question? We'll get back to you promptly.